1
|
Peis L, He G, Jost D, Rager G, Hackl R. Polarized tip-enhanced Raman spectroscopy at liquid He temperature in ultrahigh vacuum using an off-axis parabolic mirror. Rev Sci Instrum 2023; 94:063701. [PMID: 37862477 DOI: 10.1063/5.0139667] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/22/2022] [Accepted: 05/13/2023] [Indexed: 10/22/2023]
Abstract
Tip-enhanced Raman spectroscopy (TERS) combines inelastic light scattering well below the diffraction limit down to the nanometer range and scanning probe microscopy and, possibly, spectroscopy. In this way, topographic and spectroscopic as well as single- and two-particle information may simultaneously be collected. While single molecules can now be studied successfully, bulk solids are still not meaningfully accessible. It is the purpose of the work presented here to outline approaches toward this objective. We describe a home-built, liquid helium cooled, ultrahigh vacuum TERS. The setup is based on a scanning tunneling microscope and, as an innovation, an off-axis parabolic mirror having a high numerical aperture of ∼0.85 and a large working distance. The system is equipped with a fast load-lock chamber, a chamber for the in situ preparation of tips, substrates, and samples, and a TERS chamber. Base pressure and temperature in the TERS chamber were ∼3 × 10-11 mbar and 15 K, respectively. Polarization dependent tip-enhanced Raman spectra of the vibration modes of carbon nanotubes were successfully acquired at cryogenic temperature. The new features described here including very low pressure and temperature and the external access to the light polarizations, thus the selection rules, may pave the way toward the investigation of bulk and surface materials.
Collapse
Affiliation(s)
- L Peis
- Walther Meissner Institut, Bayerische Akademie der Wissenschaften, 85748 Garching, Germany
- School of Natural Sciences, Technische Universität München, 85748 Garching, Germany
- IFW Dresden, Helmholtzstrasse 20, 01069 Dresden, Germany
| | - G He
- Walther Meissner Institut, Bayerische Akademie der Wissenschaften, 85748 Garching, Germany
| | - D Jost
- Walther Meissner Institut, Bayerische Akademie der Wissenschaften, 85748 Garching, Germany
- School of Natural Sciences, Technische Universität München, 85748 Garching, Germany
| | - G Rager
- Walther Meissner Institut, Bayerische Akademie der Wissenschaften, 85748 Garching, Germany
- School of Natural Sciences, Technische Universität München, 85748 Garching, Germany
| | - R Hackl
- Walther Meissner Institut, Bayerische Akademie der Wissenschaften, 85748 Garching, Germany
- School of Natural Sciences, Technische Universität München, 85748 Garching, Germany
- IFW Dresden, Helmholtzstrasse 20, 01069 Dresden, Germany
| |
Collapse
|
2
|
Lin Q, Ding K, Zhao R, Wang H, Ren L, Wei Y, Ye Q, Cui Y, He G, Tang W, Feng Q, Zhu D, Chang W, Lv Y, Mao Y, Wang X, Liang L, Zhou G, Liang F, Xu J. 43O Preoperative chemotherapy prior to primary tumor resection for colorectal cancer patients with asymptomatic resectable primary lesion and synchronous unresectable liver-limited metastases (RECUT): A prospective, randomized, controlled, multicenter clinical trial. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.10.075] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/07/2022] Open
|
3
|
Rodriguez-Aguayo C, Bayraktar E, Ivan C, Aslan B, Mai J, He G, Mangala LS, Jiang D, Nagaraja AS, Ozpolat B, Chavez-Reyes A, Ferrari M, Mitra R, Siddik ZH, Shen H, Yang X, Sood AK, Lopez-Berestein G. Corrigendum to “PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis” [EBioMedicine 40 (2019) 290-304]. EBioMedicine 2022; 83:104194. [PMID: 35914489 PMCID: PMC9340498 DOI: 10.1016/j.ebiom.2022.104194] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
Affiliation(s)
- Cristian Rodriguez-Aguayo
- Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - Emine Bayraktar
- Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Medical Biology, Faculty of Medicine, University of Gaziantep, Gaziantep 27310, Turkey
| | - Cristina Ivan
- Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - Burcu Aslan
- Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - Junhua Mai
- Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030, USA
| | - Guangan He
- Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - Lingegowda S Mangala
- Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - Dahai Jiang
- Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - Archana S Nagaraja
- Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - Bulent Ozpolat
- Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - Arturo Chavez-Reyes
- Centro de Investigación y Estudios Avanzados del IPN, Unidad Monterrey, Apodaca, NL, CP. 66600, Mexico
| | - Mauro Ferrari
- Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030, USA
| | - Rahul Mitra
- Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - Zahid H Siddik
- Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - Haifa Shen
- Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030, USA
| | - Xianbin Yang
- AM Biotechnologies LLC, 12521 Gulf Freeway, Houston, TX 77034, USA
| | - Anil K Sood
- Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - Gabriel Lopez-Berestein
- Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
| |
Collapse
|
4
|
Wan X, Shen J, He G. Effects of Traditional Chinese Exercises on Frailty, Quality of Life, and Physical Function on Frail and Pre-Frail Older People: A Systematic Review and Meta-Analysis. J Frailty Aging 2022; 11:407-415. [DOI: 10.14283/jfa.2022.52] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
5
|
Liu SL, He SH, Wang XW, May TW, He G, Chen SL, Zhou LW. Trechisporales emended with a segregation of Sistotremastrales ord. nov. (Basidiomycota). MYCOSPHERE 2022. [DOI: 10.5943/mycosphere/13/1/11] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023] Open
|
6
|
Linden Y, Iliffe WR, He G, Danaie M, Fischer DX, Eisterer M, Speller SC, Grovenor CRM. Analysing neutron radiation damage in YBa 2 Cu 3 O 7-x high temperature superconductor tapes. J Microsc 2021; 286:3-12. [PMID: 34879153 DOI: 10.1111/jmi.13078] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2021] [Revised: 10/27/2021] [Accepted: 11/29/2021] [Indexed: 11/30/2022]
Abstract
Superconducting windings will be necessary in future fusion reactors to generate the strong magnetic fields needed to confine the plasma, and these superconducting materials will inevitably be exposed to neutron damage. It is known that this exposure results in the creation of isolated damage cascades, but the presence of these defects alone is not sufficient to explain the degradation of macroscopic superconducting properties and a quantitative method is needed to assess the subtle lattice damage in between the clusters. We have studied REBCO coated conductors irradiated with neutrons to a cumulative dose of 3.3×1022 n*m-2 that show a degradation of both Tc and Jc values, and use HRTEM analysis to show that this irradiation introduces ∼10 nm amorphous collision cascades. In addition we introduce a new method for the analysis of these images to quantify the degree of lattice disorder in the apparently perfect matrix between these cascades. This method utilises Fast Fourier and Discrete Cosine Transformations of a statistically-relevant number of HRTEM images of pristine, neutron-irradiated, and amorphous samples, and extracts the degree of randomness in terms of entropy values. Our results show that these entropy values in both mid-frequency band FFT and DCT domains correlate with the expected level of lattice damage, with the pristine samples having the lowest and the fully amorphous regions the highest entropy values. Our methodology allows us to quantify 'invisible' lattice damage to and correlate these values to the degradation of superconducting properties, and also has relevance for a wider range of applications in the field of electron microscopy where small changes in lattice perfection need to be measured. This article is protected by copyright. All rights reserved.
Collapse
Affiliation(s)
- Y Linden
- Department of Materials, University of Oxford, Parks Rd, Oxford, OX1 3PH, UK
| | - W R Iliffe
- Department of Materials, University of Oxford, Parks Rd, Oxford, OX1 3PH, UK
| | - G He
- Department of Materials, University of Oxford, Parks Rd, Oxford, OX1 3PH, UK
| | - M Danaie
- Electron Physical Sciences Imaging Centre (ePSIC), Diamond Light Source, Didcot, UK
| | - D X Fischer
- Plasma Science and Fusion Center, Massachusetts Institute of Technology, Cambridge, MA, USA
| | - M Eisterer
- Atominstitut, TU Wien, Stadionallee2, A-1020, Vienna, Austria
| | - S C Speller
- Department of Materials, University of Oxford, Parks Rd, Oxford, OX1 3PH, UK
| | - C R M Grovenor
- Department of Materials, University of Oxford, Parks Rd, Oxford, OX1 3PH, UK
| |
Collapse
|
7
|
Steino A, He G, Zhai B, Bacha J, Brown DM, Daugaard M, Siddik ZH. Abstract P053: VAL-083 (dianhydrogalactitol) synergizes with PARP inhibitors in BRCA-proficient and BRCA-deficient ovarian cancer models. Mol Cancer Ther 2021. [DOI: 10.1158/1535-7163.targ-21-p053] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Platinum (Pt)-based chemotherapy plays a key role in ovarian cancer treatment, but patients frequently develop Pt-resistance. Dysfunctional p53 is implicated in Pt-resistance, comprising a therapeutic challenge in high grade serous ovarian carcinoma (HGSOC), where p53 is universally mutated. Attempts to overcome Pt-resistance in HGSOC include agents blocking the DNA repair pathways, most notably PARP inhibitors (PARPi), leading to accumulation of DNA double strand breaks (DSBs) and cancer cell death. Sensitivity to PARPi is correlated with deficiencies in the homologous recombination (HR) DNA repair system, which accurately repairs DSBs. BRCA1 and BRCA2 are key proteins in HR, and mutated BRCA1/2 are well-established biomarkers for PARPi sensitivity. PARPi treatment of Pt-sensitive ovarian cancers have improved progression free survival; however, improvements in overall survival have not been achieved and a 5-year survival rate of 40% remains in ovarian cancer. Additionally, resistance to PARPi has emerged as a significant clinical challenge. VAL-083 is a first-in-class bifunctional DNA damaging agent with demonstrated clinical activity against a range of cancers, including ovarian. VAL-083 rapidly induces interstrand cross-links at guanine-N7 leading to DSBs, activation of the HR repair pathway and cancer cell death. VAL-083 is able to overcome cisplatin-resistance in a panel of ovarian cancer in vitro models. We have also shown that VAL-083 maintains activity independent of prominent DNA repair mechanisms implicated in resistance to numerous chemotherapeutics including cisplatin and PARPi such as MGMT, non-homologous end-joining and mismatch repair. Cancer cells thus rely heavily on a functional HR pathway for repair of VAL-083-induced DSBs. This rationalizes VAL-083 combination therapy with agents inducing DSBs or blocking their repair, including PARPi. Taken together, these data highlight VAL-083's potential for targeting Pt-resistant HGSOC in combination with PARPi. METHODS: The cytotoxicity of VAL-083 in combination with PARPi (olaparib, niraparib, rucaparib, veliparib or talazoparib) against HR-impaired (BRCA siRNA knockdown) and HR-proficient (control siRNA) ovarian cancer cells was studied. RESULTS: We report increased VAL-083 cytotoxicity against HR-impaired A2780 cancer cells. In addition, synergy between VAL-083 and olaparib, talazoparib and niraparib in both HR-proficient and deficient settings. VAL-083 combination with rucaparib produced synergistic cytotoxicity in the HR-deficient setting, while VAL-083 combination with veliparib was additive. These data demonstrate that VAL-083 can synergize with some PARPi in both HR-proficient and HR-deficient settings. CONCLUSION: Our results demonstrate a distinct DNA-damaging mechanism for VAL-083, resulting in the ability to overcome cisplatin-resistance in HR-impaired tumors. In addition, VAL-083 synergized with several PARPi, particularly olaparib, rucaparib and talazoparib, in both HR-proficient and deficient ovarian tumor cells.
Citation Format: Anne Steino, Guangan He, Beibei Zhai, Jeffrey Bacha, Dennis M. Brown, Mads Daugaard, Zahid H. Siddik. VAL-083 (dianhydrogalactitol) synergizes with PARP inhibitors in BRCA-proficient and BRCA-deficient ovarian cancer models [abstract]. In: Proceedings of the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics; 2021 Oct 7-10. Philadelphia (PA): AACR; Mol Cancer Ther 2021;20(12 Suppl):Abstract nr P053.
Collapse
Affiliation(s)
- Anne Steino
- 1Kintara Therapeutics, Inc., Vancouver, BC, Canada,
| | - Guangan He
- 2MD Anderson Cancer Center, Houston, TX,
| | - Beibei Zhai
- 3Vancouver Prostate Centre, Vancouver, BC, Canada,
| | - Jeffrey Bacha
- 4Formerly Kintara Therapeutics, Inc., Vancouver, BC, Canada,
| | | | | | | |
Collapse
|
8
|
Yu Y, Wang J, Tan Y, Wan H, Zheng N, He Z, Mao L, Ren W, Lin Z, He G, Chen Y, Wang J, Ouyang N, Yao H. 1136P A clinically applicable cervical cancer artificial intelligence screening system for accurate cytopathological diagnosis: A multicenter population-based study and randomized controlled trial. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.778] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
9
|
He G, Tao Q, Liu C, Zhang D, Zhou Y, Liu R. [Mn 2+-doped Prussian blue nanoparticles for T1-T2 dual-mode magnetic resonance imaging and photothermal therapy in vitro]. Nan Fang Yi Ke Da Xue Xue Bao 2021; 41:909-915. [PMID: 34238744 DOI: 10.12122/j.issn.1673-4254.2021.06.14] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
OBJECTIVE To prepare Mn2+-doped Prussian blue nanoparticles (Mn-PB NPs) for T1-T2 dual-mode magnetic resonance imaging (MRI) and photothermal therapy in vitro. OBJECTIVE Mn-PB NPs were prepared based on manganese chloride, ferrous chloride and potassium ferricyanide using the microemulsion method. The performance of T1-T2 dual-mode MRI with Mn-PB NPs and the photothermal property of the nanoparticles were assessed. CCK-8 assay and AM/PI double staining were used to evaluate the effect of photothermal therapy in vitro using the parepared nanoparticles. OBJECTIVE The prepared Mn-PB NPs had a mean particle size of 39.46±0.42 nm with a Zeta potential of -25.9±1.2 mV and exhibited a good dispersibility and uniform particle size. In MRI using the nanoparticles, the r1 and r2 values reached 0.68 and 3.65 (mmol/L)-1s-1, respectively, indicating good performance of Mn-PB NPs for T1 and T2 enhancement in MRI. When irradiated with 808 nm laser for 10 min, Mn-PB NPs showed a temperature rise to 90 ℃ to cause significant reduction of cell survival. CCK-8 assay and AM/PI double staining confirmed that Mn-PB NPs were capable of efficient killing of HepG2 cells upon 808 nm laser irradiation. OBJECTIVE The Mn-PB NPs prepared in this work have uniform particle size and show good performances both in MRI for T1 and T2 enhancement and in photothermal therapy in vitro without obvious cytotoxicity.
Collapse
Affiliation(s)
- G He
- School of Biomedical Engineering, Southern Medical University, Guangzhou, 510515 China
| | - Q Tao
- School of Biomedical Engineering, Southern Medical University, Guangzhou, 510515 China
| | - C Liu
- School of Biomedical Engineering, Southern Medical University, Guangzhou, 510515 China
| | - D Zhang
- School of Biomedical Engineering, Southern Medical University, Guangzhou, 510515 China
| | - Y Zhou
- School of Biomedical Engineering, Southern Medical University, Guangzhou, 510515 China
| | - R Liu
- School of Biomedical Engineering, Southern Medical University, Guangzhou, 510515 China
| |
Collapse
|
10
|
He G, Thiabaud G, Shelton KA, Segura LJ, Sessler JL, Finch RA, Siddik ZH, Arambula JF. Abstract 1073: Preclinical tissue biodistribution and plasma pharmacokinetic studies with oxaliTEX, a novel platinum(IV)-based oxaliplatin prodrug. Cancer Res 2021. [DOI: 10.1158/1538-7445.am2021-1073] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Purpose: OxaliTEX is a texaphyrin-platinum(IV) prodrug with the ability to deliver the oxaliplatin payload to cisplatin-resistant tumor cells and restore wild-type p53 activation. As a result, the conjugate overcomes both multifactorial mechanisms of cisplatin resistance and transport-defective mechanism of oxaliplatin resistance. In an effort to prepare for translational studies, we have explored its distribution and pharmacokinetics (PK) in mice.
Experimental Procedures: Athymic male and/or female nude mice (3-4/group), with or without subcutaneously implanted (flank) HCT-116 colon xenograft, received oxaliplatin (4 mg/kg) and an equimolar (17 mg/kg) or a similar therapeutic (50 mg/kg) dose of oxaliTEX iv. After 24 hours, mice were exsanguinated under anesthesia and plasma and tissues isolated. A separate group of female mice received oxaliTEX (50 mg/kg) and blood was taken at multiple times over the next 24 hours, plasma isolated and samples denatured to prepare protein-free supernatant (PFS) representing “free” platinum. Samples were analyzed for platinum (Pt) by flameless atomic absorption spectrophotometry.
Results: At equimolar doses, gross sex differences in plasma or tissue concentrations were not observed for either drug. However, plasma Pt levels with oxaliTEX (0.6-0.7 ng Pt/ml) were 7-fold greater than with oxaliplatin (0.08-0.1 ng/ml). Similarly, a 3-fold greater concentration was also noted in liver (~1.4 vs. ~0.4 ng/mg) and heart (~0.5 vs. ~0.15 ng/mg) from mice treated with the prodrug. Tissues with ≤2-fold differences between the drugs in Pt levels were testes, kidney, ovary, lung, ileum and spleen, with undetectable levels in brain. In female mice bearing HCT-116 xenografts, the general tissue distribution pattern of each drug at the therapeutic dose was unchanged and demonstrated that increasing the oxaliTEX dose resulted in proportionate increase in tissue Pt levels. Notably, tumor Pt levels were ~5-fold greater with the conjugate (oxaliTEX, 1.1 ng Pt/mg; oxaliplatin, 0.21 ng/mg). PK analysis revealed that Pt in plasma and PFS was detectable for the entire 24 hr period and decayed in a biphasic manner, with respective α-phase half-life of 0.07 and 0.2 hr and β-phase half-life of 27 and 11 hr. The AUC in plasma and PFS was 172 and 3.7 μg.hr/ml, respectively.
Conclusions: Results suggest that oxaliTEX is sequestered in the plasma by protein binding, leaving low-level systemic exposure to “free” non-protein bound Pt. Since the tissue levels are greater than oxaliplatin at equimolar and/or therapeutic doses in specific organs, this suggests that the low level exposure to “free” Pt contributes to drug tolerance of normal tissues, whereas the tumor-targeting design feature contributes to greater tumor uptake that enhances antitumor effects. Funding was provided by Cancer Prevention and Research Institute of Texas
Citation Format: Guangan He, Gregory Thiabaud, Kathyrin A. Shelton, Luke J. Segura, Jonathan L. Sessler, Rick A. Finch, Zahid H. Siddik, Jonathan F. Arambula. Preclinical tissue biodistribution and plasma pharmacokinetic studies with oxaliTEX, a novel platinum(IV)-based oxaliplatin prodrug [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2021; 2021 Apr 10-15 and May 17-21. Philadelphia (PA): AACR; Cancer Res 2021;81(13_Suppl):Abstract nr 1073.
Collapse
|
11
|
Tang J, He G, Yang Y, Li Q, He Y, Yu C, Luo L. Histological analysis of spermatogenesis and the germ cell seasonal development within the testis of domesticated tree shrews (Tupaia belangeri chinensis). Folia Morphol (Warsz) 2021; 81:412-420. [PMID: 33997948 DOI: 10.5603/fm.a2021.0048] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2021] [Revised: 04/21/2021] [Accepted: 04/22/2021] [Indexed: 11/25/2022]
Abstract
This study aimed to address the lack of information on the male germ cell seasonal development of domesticated tree shrews (Tupaia belangeri chinensis). Testicular tissues were collected from 60 tree shrews (n=5 per month). The ultrastructures of the testes and spermatids were examined via transmission electron microscopy. Apoptosis of spermatogenic cells was measured through terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining. The expression of proliferation factors, namely, proliferating cell nuclear antigen (PCNA) and Ki67, in testicular tissues was assayed through immunohistochemistry. Spermatids ultrastructure showed seasonal differences, and spermatogenesis was relatively active in June and July and relatively stagnant from October to November. The percentage of TUNEL-positive germ cells was less during October and November, while greater in July than other phases. The number of PCNA-nucleus-positive germ cells was most in June and July, but with cytoplasm staining from October to November. Ki67 presented positive expression in the testes from April to September, with highest expression in June, but with no expression from October to March. In summary, there are seasonal differences in tissue morphology related to spermatogenesis in domesticated tree shrews. PCNA expression and Ki67 expression are good indicators of seasonal differences in male germ cells.
Collapse
Affiliation(s)
- J Tang
- Kunming Medical University, No. 1168 Chunrong West Road, Yuhua Street, Chenggong, Kunming, 650032 Kunming, China.,Kunming Maternity and Child Health Hospital, Kunming, China
| | - G He
- Kunming Medical University, No. 1168 Chunrong West Road, Yuhua Street, Chenggong, Kunming, 650032 Kunming, China.,Yunnan Maternal and Child Health Care Hospital, Kunming, China
| | - Y Yang
- Kunming Medical University, No. 1168 Chunrong West Road, Yuhua Street, Chenggong, Kunming, 650032 Kunming, China
| | - Q Li
- Kunming Medical University, No. 1168 Chunrong West Road, Yuhua Street, Chenggong, Kunming, 650032 Kunming, China
| | - Y He
- Kunming Medical University, No. 1168 Chunrong West Road, Yuhua Street, Chenggong, Kunming, 650032 Kunming, China
| | - C Yu
- Kunming Medical University, No. 1168 Chunrong West Road, Yuhua Street, Chenggong, Kunming, 650032 Kunming, China
| | - L Luo
- Kunming Medical University, No. 1168 Chunrong West Road, Yuhua Street, Chenggong, Kunming, 650032 Kunming, China.
| |
Collapse
|
12
|
Arabchigavkani N, Somphonsane R, Ramamoorthy H, He G, Nathawat J, Yin S, Barut B, He K, Randle MD, Dixit R, Sakanashi K, Aoki N, Zhang K, Wang L, Mei WN, Dowben PA, Fransson J, Bird JP. Remote Mesoscopic Signatures of Induced Magnetic Texture in Graphene. Phys Rev Lett 2021; 126:086802. [PMID: 33709762 DOI: 10.1103/physrevlett.126.086802] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/15/2020] [Accepted: 01/19/2021] [Indexed: 06/12/2023]
Abstract
Mesoscopic conductance fluctuations are a ubiquitous signature of phase-coherent transport in small conductors, exhibiting universal character independent of system details. In this Letter, however, we demonstrate a pronounced breakdown of this universality, due to the interplay of local and remote phenomena in transport. Our experiments are performed in a graphene-based interaction-detection geometry, in which an artificial magnetic texture is induced in the graphene layer by covering a portion of it with a micromagnet. When probing conduction at some distance from this region, the strong influence of remote factors is manifested through the appearance of giant conductance fluctuations, with amplitude much larger than e^{2}/h. This violation of one of the fundamental tenets of mesoscopic physics dramatically demonstrates how local considerations can be overwhelmed by remote signatures in phase-coherent conductors.
Collapse
Affiliation(s)
- N Arabchigavkani
- Department of Physics, University at Buffalo, the State University of New York, Buffalo, New York 14260, USA
| | - R Somphonsane
- Department of Physics, King Mongkut's Institute of Technology Ladkrabang, Bangkok 10520, Thailand
| | - H Ramamoorthy
- Department of Electronics Engineering, King Mongkut's Institute of Technology Ladkrabang, Bangkok 10520, Thailand
| | - G He
- Department of Electrical Engineering, University at Buffalo, the State University of New York, Buffalo, New York 14260, USA
| | - J Nathawat
- Department of Electrical Engineering, University at Buffalo, the State University of New York, Buffalo, New York 14260, USA
| | - S Yin
- Department of Electrical Engineering, University at Buffalo, the State University of New York, Buffalo, New York 14260, USA
| | - B Barut
- Department of Physics, University at Buffalo, the State University of New York, Buffalo, New York 14260, USA
| | - K He
- Department of Electrical Engineering, University at Buffalo, the State University of New York, Buffalo, New York 14260, USA
| | - M D Randle
- Department of Electrical Engineering, University at Buffalo, the State University of New York, Buffalo, New York 14260, USA
| | - R Dixit
- Department of Electrical Engineering, University at Buffalo, the State University of New York, Buffalo, New York 14260, USA
| | - K Sakanashi
- Department of Materials Science, Chiba University, Chiba 263-8522, Japan
| | - N Aoki
- Department of Materials Science, Chiba University, Chiba 263-8522, Japan
| | - K Zhang
- Department of Materials Science and Engineering, University of Science and Technology of China, Hefei, Anhui 230026, China
| | - L Wang
- Department of Materials Science and Engineering, University of Science and Technology of China, Hefei, Anhui 230026, China
| | - W-N Mei
- Department of Physics, University of Nebraska Omaha, Omaha, Nebraska 68182, USA
| | - P A Dowben
- Department of Physics and Astronomy, Theodore Jorgensen Hall, University of Nebraska Lincoln, Lincoln, Nebraska 68588-0299, USA
| | - J Fransson
- Department of Physics and Astronomy, Uppsala University, Box 516, SE-751 21 Uppsala, Sweden
| | - J P Bird
- Department of Electrical Engineering, University at Buffalo, the State University of New York, Buffalo, New York 14260, USA
| |
Collapse
|
13
|
Hong B, Chapa V, Saini U, Modgil P, Cohn DE, He G, Siddik ZH, Sood AK, Yan Y, Selvendiran K, Pei G, Zhao Z, Yoo JY, Kaur B. Oncolytic HSV Therapy Modulates Vesicular Trafficking Inducing Cisplatin Sensitivity and Antitumor Immunity. Clin Cancer Res 2021; 27:542-553. [PMID: 33087329 PMCID: PMC8147278 DOI: 10.1158/1078-0432.ccr-20-2210] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2020] [Revised: 08/27/2020] [Accepted: 10/16/2020] [Indexed: 12/12/2022]
Abstract
PURPOSE Here we investigated the impact of oncolytic herpes simplex virus (HSV) treatment on cisplatin sensitivity of platinum-resistant ovarian cancer, and the impact of the combination on immunotherapy. EXPERIMENTAL DESIGN Therapeutic efficacy of the combination was assessed in platinum-resistant human and murine ovarian cancer peritoneal metastatic mouse models (n = 9-10/group). RNA sequencing along with flow cytometry of splenocytes from treated mice was employed to examine the effect of antitumor immune response (n = 3/group). Anti-PD-1 antibody was performed to evaluate impact on checkpoint inhibition in vivo. RESULTS Gene Ontology pathway analysis uncovered disruption of cellular extracellular vesicle (EV)-related pathways in infected cells (FDR = 2.97E-57). Mechanistically, we identified reduced expression of transporters expressed on EV implicated in cisplatin efflux. The increased cisplatin retention led to increased cisplatin-DNA adducts, which resulted in micronuclei and the subsequent activation of cGAS-STING pathway with a significant activation of innate immune cells and translated to an increase in antitumor immunity and efficacy. In mice bearing platinum-resistant ovarian cancer, we also observed a feedback induction of PD-L1 on tumor cells, which sensitized combination-treated mice to anti-PD-1 immune checkpoint therapy. CONCLUSIONS To our knowledge, this is the first report to show HSV-induced cisplatin retention in infected cells. The consequential increased damaged DNA was then expelled from cells as micronuclei which resulted in induction of inflammatory responses and education of antitumor immunity. The combination therapy also created an environment that sensitized tumors to immune checkpoint therapy.
Collapse
Affiliation(s)
- Bangxing Hong
- Department of Neurosurgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas.
| | - Valerie Chapa
- Department of Neurosurgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas
| | - Uksha Saini
- Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, Ohio
| | - Puneet Modgil
- Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, Ohio
| | - David E Cohn
- Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, Ohio
| | - Guangan He
- Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas
| | - Zahid H Siddik
- Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas
| | - Anil K Sood
- Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
| | - Yuanqing Yan
- Department of Neurosurgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas
| | - Karuppaiyah Selvendiran
- Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, Ohio
| | - Guangsheng Pei
- Center for Precision Health, School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, Texas
| | - Zhongming Zhao
- Center for Precision Health, School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, Texas
- Human Genetics Center, School of Public Health, The University of Texas Health Science Center at Houston, Houston, Texas
| | - Ji Young Yoo
- Department of Neurosurgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas
| | - Balveen Kaur
- Department of Neurosurgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas.
| |
Collapse
|
14
|
He G, Li D, Jost D, Baum A, Shen PP, Dong XL, Zhao ZX, Hackl R. Raman Study of Cooper Pairing Instabilities in (Li_{1-x}Fe_{x})OHFeSe. Phys Rev Lett 2020; 125:217002. [PMID: 33274977 DOI: 10.1103/physrevlett.125.217002] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/20/2020] [Accepted: 10/15/2020] [Indexed: 06/12/2023]
Abstract
We studied the electronic Raman spectra of (Li_{1-x}Fe_{x})OHFeSe as a function of light polarization and temperature. In the B_{1g} spectra alone we observe the redistribution of spectral weight expected for a superconductor and two well-resolved peaks below T_{c}. The nearly resolution-limited peak at 110 cm^{-1} (13.6 meV) is identified as a collective mode. The peak at 190 cm^{-1} (23.6 meV) is presumably another collective mode since the line is symmetric and its energy is significantly below the gap energy observed by single-particle spectroscopies. Given the experimental band structure of (Li_{1-x}Fe_{x})OHFeSe, the most plausible explanations include conventional spin-fluctuation pairing between the electron bands and the incipient hole band and pairing between the hybridized electron bands. The absence of gap features in A_{1g} and B_{2g} symmetry favors the second case. Thus, in spite of various differences between the pnictides and chalcogenides, this Letter demonstrates the proximity of pairing states and the importance of band structure effects in the Fe-based compounds.
Collapse
Affiliation(s)
- G He
- Walther Meissner Institut, Bayerische Akademie der Wissenschaften, 85748 Garching, Germany
| | - D Li
- Beijing National Laboratory for Condensed Matter Physics, Institute of Physics, Chinese Academy of Sciences, Beijing 100190, China
- School of Physical Sciences, University of Chinese Academy of Sciences, Beijing 100049, China
| | - D Jost
- Walther Meissner Institut, Bayerische Akademie der Wissenschaften, 85748 Garching, Germany
- Fakultät für Physik E23, Technische Universität München, 85748 Garching, Germany
| | - A Baum
- Walther Meissner Institut, Bayerische Akademie der Wissenschaften, 85748 Garching, Germany
| | - P P Shen
- Beijing National Laboratory for Condensed Matter Physics, Institute of Physics, Chinese Academy of Sciences, Beijing 100190, China
- School of Physical Sciences, University of Chinese Academy of Sciences, Beijing 100049, China
| | - X L Dong
- Beijing National Laboratory for Condensed Matter Physics, Institute of Physics, Chinese Academy of Sciences, Beijing 100190, China
- School of Physical Sciences, University of Chinese Academy of Sciences, Beijing 100049, China
- Songshan Lake Materials Laboratory, Dongguan, Guangdong 523808, China
| | - Z X Zhao
- Beijing National Laboratory for Condensed Matter Physics, Institute of Physics, Chinese Academy of Sciences, Beijing 100190, China
- School of Physical Sciences, University of Chinese Academy of Sciences, Beijing 100049, China
- Songshan Lake Materials Laboratory, Dongguan, Guangdong 523808, China
| | - R Hackl
- Walther Meissner Institut, Bayerische Akademie der Wissenschaften, 85748 Garching, Germany
- Fakultät für Physik E23, Technische Universität München, 85748 Garching, Germany
| |
Collapse
|
15
|
Somphonsane R, Ramamoorthy H, He G, Nathawat J, Yin S, Kwan CP, Arabchigavkani N, Barut B, Zhao M, Jin Z, Fransson J, Bird JP. Universal scaling of weak localization in graphene due to bias-induced dispersion decoherence. Sci Rep 2020; 10:5611. [PMID: 32221340 PMCID: PMC7101405 DOI: 10.1038/s41598-020-62313-3] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2019] [Accepted: 03/11/2020] [Indexed: 11/29/2022] Open
Abstract
The differential conductance of graphene is shown to exhibit a zero-bias anomaly at low temperatures, arising from a suppression of the quantum corrections due to weak localization and electron interactions. A simple rescaling of these data, free of any adjustable parameters, shows that this anomaly exhibits a universal, temperature- (T) independent form. According to this, the differential conductance is approximately constant at small voltages (V < kBT/e), while at larger voltages it increases logarithmically with the applied bias. For theoretical insight into the origins of this behaviour, which is inconsistent with electron heating, we formulate a model for weak-localization in the presence of nonequilibrium transport. According to this model, the applied voltage causes unavoidable dispersion decoherence, which arises as diffusing electron partial waves, with a spread of energies defined by the value of the applied voltage, gradually decohere with one another as they diffuse through the system. The decoherence yields a universal scaling of the conductance as a function of eV/kBT, with a logarithmic variation for eV/kBT > 1, variations in accordance with the results of experiment. Our theoretical description of nonequilibrium transport in the presence of this source of decoherence exhibits strong similarities with the results of experiment, including the aforementioned rescaling of the conductance and its logarithmic variation as a function of the applied voltage.
Collapse
Affiliation(s)
- R Somphonsane
- Department of Physics, King Mongkut's Institute of Technology Ladkrabang, Bangkok, 10520, Thailand.
- Thailand Center of Excellence in Physics, Commission on Higher Education, 328 Si Ayutthaya Road, Bangkok, 10400, Thailand.
| | - H Ramamoorthy
- Department of Electronic Engineering, King Mongkut's Institute of Technology Ladkrabang, Bangkok, 10520, Thailand
| | - G He
- Department of Electrical Engineering, University at Buffalo, The State University of New York, Buffalo, NY, 14260-1900, USA
| | - J Nathawat
- Department of Electrical Engineering, University at Buffalo, The State University of New York, Buffalo, NY, 14260-1900, USA
| | - S Yin
- Department of Electrical Engineering, University at Buffalo, The State University of New York, Buffalo, NY, 14260-1900, USA
| | - C-P Kwan
- Department of Physics, University at Buffalo, The State University of New York, Buffalo, NY, 14260-1500, USA
| | - N Arabchigavkani
- Department of Physics, University at Buffalo, The State University of New York, Buffalo, NY, 14260-1500, USA
| | - B Barut
- Department of Physics, University at Buffalo, The State University of New York, Buffalo, NY, 14260-1500, USA
| | - M Zhao
- High-Frequency High-Voltage Device and Integrated Circuits Center, Institute of Microelectronics of Chinese Academy of Sciences, 3 Beitucheng West Road, Chaoyang District, Beijing, PR China
| | - Z Jin
- High-Frequency High-Voltage Device and Integrated Circuits Center, Institute of Microelectronics of Chinese Academy of Sciences, 3 Beitucheng West Road, Chaoyang District, Beijing, PR China
| | - J Fransson
- Department of Physics and Astronomy, Uppsala University, Box 516, SE-751 21, Uppsala, Sweden
| | - J P Bird
- Department of Electrical Engineering, University at Buffalo, The State University of New York, Buffalo, NY, 14260-1900, USA
| |
Collapse
|
16
|
Wang CH, Hou R, Wang M, He G, Li BG, Pan RL. Effects of wet atmospheric nitrogen deposition on epiphytic lichens in the subtropical forests of Central China: Evaluation of the lichen food supply and quality of two endangered primates. Ecotoxicol Environ Saf 2020; 190:110128. [PMID: 31891838 DOI: 10.1016/j.ecoenv.2019.110128] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/18/2019] [Revised: 12/18/2019] [Accepted: 12/21/2019] [Indexed: 06/10/2023]
Abstract
Over the last few decades, the threat posed to biodiversity and ecosystem function by atmospheric nitrogen (N) deposition has been increasingly recognized. The disturbed nutrient balance and species composition of plants induced by higher N deposition can impact the biodiversity of the organisms that consume the plants. In this research, we implemented several experiments to estimate the effects of increased N deposition on the growth, survival, and nutrients of the dominant epiphytic lichens in the subtropical mountains in Central China to assess the lichen food amount and nutritional quality for two endangered primates endemic to China. Our results indicated that the thallus growth and propagule survival of the lichens were significantly decreased when nitrogen addition changed from 6.25 to 50.0 kg N·ha-1·y-1; it was also shown that lichen biomass could be decreased by 11.2%-70.2% when the deposition addition exceeded 6.25 kg N·ha-1·y-1. Further, our study revealed that increased nitrogen deposition also reduced the nutritional quality of the lichens via reducing the soluble protein and soluble sugar levels and increasing the fiber content, which would substantially affect the diet selection of the plants consumers in the region, particularly the populations of the two lichen-eating endangered primate species, Rhinopithecus roxellana and R. bieti. Our experimental study suggested that the nitrogen pollution derived from anthropogenic activities could cause cascading effects for the whole forest ecosystem of Central China; thus, more studies about nitrogen deposition in this region are required.
Collapse
Affiliation(s)
- C H Wang
- Engineering Research Centre of Eco-Environment in the Three Gorges Reservoir Region, Ministry of Education, China Three Gorges University, Daxue Road 8th, Yichang, Hubei Province, 443002, PR China; Hubei International Scientific and Technological Cooperation Centre of Ecological Protection and Management in the Three Gorges Area, China Three Gorges University, Daxue Road 8th, Yichang, Hubei Province, 443002, PR China.
| | - R Hou
- Department of Anthropology, McGill University, Montreal, QC, H3A 2T7, Canada; Shaanxi Key Laboratory for Animal Conservation, Northwest University, Xi'an, 710069, PR China
| | - M Wang
- Engineering Research Centre of Eco-Environment in the Three Gorges Reservoir Region, Ministry of Education, China Three Gorges University, Daxue Road 8th, Yichang, Hubei Province, 443002, PR China
| | - G He
- Shaanxi Key Laboratory for Animal Conservation, Northwest University, Xi'an, 710069, PR China
| | - B G Li
- Shaanxi Key Laboratory for Animal Conservation, Northwest University, Xi'an, 710069, PR China; Xi'an Branch of Chinese Academy of Sciences, Xi'an, 710043, PR China
| | - R L Pan
- Shaanxi Key Laboratory for Animal Conservation, Northwest University, Xi'an, 710069, PR China; School of Human Sciences and Centre for Evolutionary Biology, School of Biological Sciences, The University of Western Australia, Perth, WA, 6009, Australia
| |
Collapse
|
17
|
Xie X, He G, Siddik ZH. Cisplatin in Combination with MDM2 Inhibition Downregulates Rad51 Recombinase in a Bimodal Manner to Inhibit Homologous Recombination and Augment Tumor Cell Kill. Mol Pharmacol 2020; 97:237-249. [PMID: 32063580 DOI: 10.1124/mol.119.117564] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2019] [Accepted: 01/15/2020] [Indexed: 01/22/2023] Open
Abstract
Dysfunction of p53 and resistance to cancer drugs can arise through mutually exclusive overexpression of MDM2 or MDM4. Cisplatin-resistant cells, however, can demonstrate increased binding of both MDM2 and MDM4 to p53 but in absence of cellular overexpression. Whether MDM2 inhibitors alone can activate p53 in these resistant cells was investigated with the goal to establish the mechanism for potential synergy with cisplatin. Thus, growth inhibition by individual drugs and combinations was assessed by a colorimetric assay. Drug-treated parental A2780 and resistant tumor cells were also examined for protein expression using immunoblot and reverse phase protein array (RPPA) and then subjected to Ingenuity Pathway Analysis (IPA). Gene expression was assessed by real-time polymerase chain reaction, DNA damage by confocal microscopy, cell cycle by flow cytometry, and homologous recombination (HR) by a GFP reporter assay. Our results demonstrate that Nutlin-3 but not RITA (reactivation of p53 and induction of tumor cell apoptosis) effectively disrupted the p53-MDM2-MDM4 complex to activate p53, which increased robustly with cisplatin/Nutlin-3 combination and enhanced antitumor effects more than either agent alone. RPPA, IPA, and confocal microscopy provided evidence for an "apparent" increase in DNA damage resulting from HR inhibition by cisplatin/Nutlin-3. Molecularly, the specific HR protein Rad51 was severely downregulated by the combination via two mechanisms: p53-dependent transrepression and p53/MDM2-mediated proteasomal degradation. In conclusion, Nutlin-3 fully destabilizes the p53-MDM2-MDM4 complex and synergizes with cisplatin to intensify p53 function, which then downregulates Rad51 through a bimodal mechanism. As a result, HR is inhibited and antitumor activity enhanced in otherwise HR-proficient sensitive and resistant tumor cells. SIGNIFICANCE STATEMENT: Rad51 downregulation by the combination of cisplatin and Nutlin-3 inhibits homologous recombination (HR), which leads to persistence in DNA damage but not an increase. Thus, inhibition of HR enhances antitumor activity in otherwise HR-proficient sensitive and resistant tumor cells.
Collapse
Affiliation(s)
- Xiaolei Xie
- Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas
| | - Guangan He
- Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas
| | - Zahid H Siddik
- Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas
| |
Collapse
|
18
|
Steino A, He G, Bacha J, Brown DM, Siddik ZH. Abstract NT-109: VAL-083 (DIANHYDROGALACTITOL) SYNERGIZES WITH PARP INHIBITORS IN BRCA-PROFICIENT AND BRCA-DEFICIENT OVARIAN CANCER MODELS. Clin Cancer Res 2019. [DOI: 10.1158/1557-3265.ovcasymp18-nt-109] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
BACKGROUND: Ovarian cancer is normally treated with platinum (Pt)-based chemotherapy, but patients frequently develop Pt-resistance. Dysfunctional p53 is implicated in Pt-resistance, comprising a therapeutic challenge in high grade serous ovarian carcinoma (HGSC), where p53 is universally mutated (96%). Attempts to overcome Pt-resistance in HGSC include agents blocking the DNA repair pathways, most notably the PARP inhibitors (PARPi), leading to the accumulation of DNA double strand breaks (DSBs) and cancer cell death. Sensitivity to PARPi is correlated with deficiencies in the homologous recombination (HR) DNA repair system, which is in charge of accurately repairing DSBs. BRCA1 and BRCA2 are key proteins in HR, and mutated BRCA1/2 (present in 20% of HGSC) are well-established biomarkers for PARPi sensitivity. PARPi treatment of Pt-sensitive gynecologic malignancies have improved progression free survival (PFS); however, improvements in overall survival have not been achieved and a 5-year survival rate of only 40% remains in ovarian cancer. Additionally, resistance to PARPi in the clinical setting is emerging as a significant medical challenge. VAL-083 is a first-in-class bifunctional DNA damaging agent with demonstrated clinical activity against a range of cancers, including ovarian. VAL-083 rapidly induces interstrand cross-links at guanine-N7 leading to DSBs, activation of the HR repair pathway and cancer cell death. Notably, VAL-083 induces cell death through two parallel pathways - one p53-independent and one p53-dependent. We have shown that VAL-083 is able to overcome cisplatin-resistance in a panel of ovarian cancer in vitro models, independent of p53 status. We have also shown that VAL-083 maintains activity independent of prominent DNA repair mechanisms such as O6-methylguanine DNA methyltransferase (MGMT), non-homologous end-joining (NHEJ) and mismatch repair (MMR) implicated in resistance to numerous chemotherapeutics, including cisplatin and PARPi. Cancer cells thus rely heavily on functional HR pathway for repair of VAL-083-induced DSBs. This suggests combination therapy with agents further inducing DSBs or blocking their repair, including PARPi. Taken together, these data propose VAL-083's potential for targeting Pt-resistant HGSC and for combination treatment with PARPi.
METHODS: In this study, we examined the cytotoxicity of VAL-083 in combination with PARPi (olaparib, niraparib, rucaparib, veliparib or talazoparib) against HR-proficient and HR-impaired ovarian cancer cells. VAL-083 cytotoxicity alone and in combination with PARPi was investigated using the 5-day MTT assay in HR-proficient (control siRNA) and HR-impaired (BRCA1 siRNA knockdown) A2780 ovarian cancer cells. RESULTS: We report increased VAL-083 cytotoxicity against HR-impaired A2780 cancer cells. We further report synergy between VAL-083 and PARPi olaparib, talazoparib and niraparib in both HR-proficient and HR-deficient settings. VAL-083 combination with rucaparib produced synergistic cytotoxicity in the HR-deficient setting, while VAL-083 combination with veliparib was no more than additive. These data demonstrate that VAL-083 can synergize with some PARP inhibitors in both a HR-proficient and HR-deficient setting.
CONCLUSION: Our results demonstrate a distinct DNA damaging mechanism for VAL-083, resulting in the ability to overcome cisplatin-resistance, target HR-impaired tumors and overcome MGMT, MMR and NHEJ-related chemoresistance. In addition, VAL-083 synergized with several PARPi, particularly olaparib, rucaparib and talazoparib, in both HR-proficient and HR-deficient ovarian tumor cells.
Citation Format: Anne Steino, Guangan He, Jeffrey Bacha, Dennis M. Brown and Zahid H. Siddik. VAL-083 (DIANHYDROGALACTITOL) SYNERGIZES WITH PARP INHIBITORS IN BRCA-PROFICIENT AND BRCA-DEFICIENT OVARIAN CANCER MODELS [abstract]. In: Proceedings of the 12th Biennial Ovarian Cancer Research Symposium; Sep 13-15, 2018; Seattle, WA. Philadelphia (PA): AACR; Clin Cancer Res 2019;25(22 Suppl):Abstract nr NT-109.
Collapse
Affiliation(s)
- Anne Steino
- 1DelMar Pharmaceuticals, Inc, Vancouver, Canada and Menlo Park, CA,
| | - Guangan He
- 2The University of Texas MD Anderson Cancer Center, Houston, TX
| | - Jeffrey Bacha
- 1DelMar Pharmaceuticals, Inc, Vancouver, Canada and Menlo Park, CA,
| | - Dennis M. Brown
- 1DelMar Pharmaceuticals, Inc, Vancouver, Canada and Menlo Park, CA,
| | - Zahid H. Siddik
- 2The University of Texas MD Anderson Cancer Center, Houston, TX
| |
Collapse
|
19
|
Xu J, Liu T, Tang W, Chang W, Feng Q, Wei Y, Ren L, Ye Q, Cui Y, He G, Liu T, Zhu D, Ji M. Bevacizumab plus chemotherapy versus chemotherapy alone as first-line treatment for patients with RAS mutant unresectable colorectal liver-limited metastases: A single center randomized control trial. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz394.020] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
20
|
Chang W, Liu T, Ye W, Ren L, He G, Xu J. Detection of 5-hydroxymethylcytosine in circulating-free DNA for prediction of the efficacy of conversion therapy for colorectal cancer liver metastases. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz246.106] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
21
|
Liu T, Chang W, Ye W, He G, Ren L, Tang W, Chen J, Xu J. Detection of 5-hydroxymethylcytosine in circulating-free DNA for early diagnosis of colorectal cancer. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz246.105] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
22
|
Li Q, Luo H, Peng H, Zhong M, Liu X, Qiu D, Yang H, He Y, Li C, Yin L, Huang X, Tian X, He G, Wang Y, Jin F. Plan Quality Evaluation and Preliminary Application of a Novel Plan Difficulty Index in Radiotherapy of Lung Cancer. Int J Radiat Oncol Biol Phys 2019. [DOI: 10.1016/j.ijrobp.2019.06.850] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
23
|
Abstract
The H8 subtype viruses are rarely isolated from wild ducks. Shanghai is one of the important wintering or stopover sites on the East Asia-Australia Migration Flyway. An influenza virus, subtype H8N4, was firstly isolated from a common teal (Anas crecca) in Shanghai during 2017-2018 in this study. To clarify the genetic characteristics of the H8N4 virus, the whole genome sequences were analyzed. Phylogenetic analysis of the hemagglutinin and neuraminidase genes showed that they shared highest nucleotide identity (99.19%-99.64%) with the Japan duck-origin H8N4 virus collected in 2016 (A/duck/Aichi/231003/2016) and belonged to the Eurasian-like avian lineage. Six other genes of the H8N4 isolated virus were all highly similar to the corresponding genes of a wide range of AIV subtypes including H9N2, H5N7, H3N8, H1N2, H4N6 and H1N1. The results indicated that the H8N4 virus was a multiple reassortant virus. The study emphasized that the continuous surveillance of influenza virus in wild birds should be strengthened. Keywords: avian influenza virus; H8N4; phylogenetic analysis; Shanghai.
Collapse
|
24
|
Rodriguez-Aguayo C, Bayraktar E, Ivan C, Aslan B, Mai J, He G, Mangala LS, Jiang D, Nagaraja AS, Ozpolat B, Chavez-Reyes A, Ferrari M, Mitra R, Siddik ZH, Shen H, Yang X, Sood AK, Lopez-Berestein G. PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis. EBioMedicine 2019; 40:290-304. [PMID: 30655206 PMCID: PMC6411965 DOI: 10.1016/j.ebiom.2018.11.045] [Citation(s) in RCA: 28] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/28/2018] [Revised: 11/07/2018] [Accepted: 11/21/2018] [Indexed: 02/04/2023] Open
Abstract
Background Inflammatory mediator prostaglandin E2–prostaglandin E2 receptor EP3 (PTGER3) signaling is critical for tumor-associated angiogenesis, tumor growth, and chemoresistance. However, the mechanism underlying these effects in ovarian cancer is not known. Methods An association between higher tumoral expression of PTGER3 and shorter patient survival in the ovarian cancer dataset of The Cancer Genome Atlas prompted investigation of the antitumor effects of PTGER3 downmodulation. PTGER3 mRNA and protein levels were higher in cisplatin-resistant ovarian cancer cells than in their cisplatin-sensitive counterparts. Findings Silencing of PTGER3 via siRNA in cancer cells was associated with decreased cell growth and less invasiveness, as well as cell-cycle arrest and increased apoptosis, mediated through the Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis. Furthermore, sustained PTGER3 silencing with multistage vector and liposomal 2’-F-phosphorodithioate-siRNA–mediated silencing of PTGER3 combined with cisplatin resulted in robust antitumor effects in cisplatin-resistant ovarian cancer models. Interpretation These findings identify PTGER3 as a potential therapeutic target in chemoresistant ovarian cancers expressing high levels of this oncogenic protein. Fund National Institutes of Health/National Cancer Institute, USA.
Collapse
Affiliation(s)
- Cristian Rodriguez-Aguayo
- Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - Emine Bayraktar
- Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Medical Biology, Faculty of Medicine, University of Gaziantep, Gaziantep 27310, Turkey
| | - Cristina Ivan
- Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - Burcu Aslan
- Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - Junhua Mai
- Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030, USA
| | - Guangan He
- Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - Lingegowda S Mangala
- Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - Dahai Jiang
- Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - Archana S Nagaraja
- Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - Bulent Ozpolat
- Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - Arturo Chavez-Reyes
- Centro de Investigación y Estudios Avanzados del IPN, Unidad Monterrey, Apodaca, NL, CP. 66600, Mexico
| | - Mauro Ferrari
- Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030, USA
| | - Rahul Mitra
- Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - Zahid H Siddik
- Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - Haifa Shen
- Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030, USA
| | - Xianbin Yang
- AM Biotechnologies LLC, 12521 Gulf Freeway, Houston, TX 77034, USA
| | - Anil K Sood
- Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
| | - Gabriel Lopez-Berestein
- Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
| |
Collapse
|
25
|
Du D, Liu M, Xing Y, Chen X, Zhang Y, Zhu M, Lu X, Zhang Q, Ling Y, Sang X, Li Y, Zhang C, He G. Semi-dominant mutation in the cysteine-rich receptor-like kinase gene, ALS1, conducts constitutive defence response in rice. Plant Biol (Stuttg) 2019; 21:25-34. [PMID: 30101415 DOI: 10.1111/plb.12896] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/01/2018] [Accepted: 08/04/2018] [Indexed: 06/08/2023]
Abstract
Plants have evolved a sophisticated two-branch defence system to prevent the growth and spread of pathogen infection. The novel Cys-rich repeat (CRR) containing receptor-like kinases, known as CRKs, were reported to mediate defence resistance in plants. For rice, there are only two reports of CRKs. A semi-dominant lesion mimic mutant als1 (apoptosis leaf and sheath 1) in rice was identified to demonstrate spontaneous lesions on the leaf blade and sheath. A map-based cloning strategy was used for fine mapping and cloning of ALS1, which was confirmed to be a typical CRK in rice. Functional studies of ALS1 were conducted, including phylogenetic analysis, expression analysis, subcellular location and blast resistance identification. Most pathogenesis-related (PR) genes and other defence-related genes were activated and up-regulated to a high degree. ALS1 was expressed mainly in the leaf blade and sheath, in which further study revealed that ALS1 was present in the vascular bundles. ALS1 was located in the cell membrane of rice protoplasts, and its mutation did not change its subcellular location. Jasmonic acid (JA) and salicylic acid (SA) accumulation were observed in als1, and enhanced blast resistance was also observed. The mutation of ALS1 caused a constitutively activated defence response in als1. The results of our study imply that ALS1 participates in a defence response resembling the common SA-, JA- and NH1-mediated defence responses in rice.
Collapse
Affiliation(s)
- D Du
- Rice Research Institute, Key Laboratory of Application and Safety Control of Genetically Modified Crops, Academy of Agricultural Sciences, Southwest University, Chongqing, 400715, China
| | - M Liu
- Rice Research Institute, Key Laboratory of Application and Safety Control of Genetically Modified Crops, Academy of Agricultural Sciences, Southwest University, Chongqing, 400715, China
| | - Y Xing
- Rice Research Institute, Key Laboratory of Application and Safety Control of Genetically Modified Crops, Academy of Agricultural Sciences, Southwest University, Chongqing, 400715, China
| | - X Chen
- Rice Research Institute, Key Laboratory of Application and Safety Control of Genetically Modified Crops, Academy of Agricultural Sciences, Southwest University, Chongqing, 400715, China
| | - Y Zhang
- Rice Research Institute, Key Laboratory of Application and Safety Control of Genetically Modified Crops, Academy of Agricultural Sciences, Southwest University, Chongqing, 400715, China
| | - M Zhu
- Rice Research Institute, Key Laboratory of Application and Safety Control of Genetically Modified Crops, Academy of Agricultural Sciences, Southwest University, Chongqing, 400715, China
| | - X Lu
- Rice Research Institute, Key Laboratory of Application and Safety Control of Genetically Modified Crops, Academy of Agricultural Sciences, Southwest University, Chongqing, 400715, China
| | - Q Zhang
- Rice Research Institute, Key Laboratory of Application and Safety Control of Genetically Modified Crops, Academy of Agricultural Sciences, Southwest University, Chongqing, 400715, China
| | - Y Ling
- Rice Research Institute, Key Laboratory of Application and Safety Control of Genetically Modified Crops, Academy of Agricultural Sciences, Southwest University, Chongqing, 400715, China
| | - X Sang
- Rice Research Institute, Key Laboratory of Application and Safety Control of Genetically Modified Crops, Academy of Agricultural Sciences, Southwest University, Chongqing, 400715, China
| | - Y Li
- Rice Research Institute, Key Laboratory of Application and Safety Control of Genetically Modified Crops, Academy of Agricultural Sciences, Southwest University, Chongqing, 400715, China
| | - C Zhang
- Rice Research Institute, Key Laboratory of Application and Safety Control of Genetically Modified Crops, Academy of Agricultural Sciences, Southwest University, Chongqing, 400715, China
| | - G He
- Rice Research Institute, Key Laboratory of Application and Safety Control of Genetically Modified Crops, Academy of Agricultural Sciences, Southwest University, Chongqing, 400715, China
| |
Collapse
|
26
|
Zhao J, He G, Huang S, Villalobos LF, Dakhchoune M, Bassas H, Agrawal KV. Etching gas-sieving nanopores in single-layer graphene with an angstrom precision for high-performance gas mixture separation. Sci Adv 2019; 5:eaav1851. [PMID: 30746475 PMCID: PMC6357726 DOI: 10.1126/sciadv.aav1851] [Citation(s) in RCA: 89] [Impact Index Per Article: 17.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/23/2018] [Accepted: 12/10/2018] [Indexed: 05/19/2023]
Abstract
One of the bottlenecks in realizing the potential of atom-thick graphene membrane for gas sieving is the difficulty in incorporating nanopores in an otherwise impermeable graphene lattice, with an angstrom precision at a high-enough pore density. We realize this design by developing a synergistic, partially decoupled defect nucleation and pore expansion strategy using O2 plasma and O3 treatment. A high density (ca. 2.1 × 1012 cm-2) of H2-sieving pores was achieved while limiting the percentage of CH4-permeating pores to 13 to 22 parts per million. As a result, a record-high gas mixture separation performance was achieved (H2 permeance, 1340 to 6045 gas permeation units; H2/CH4 separation factor, 15.6 to 25.1; H2/C3H8 separation factor, 38.0 to 57.8). This highly scalable pore etching strategy will accelerate the development of single-layer graphene-based energy-efficient membranes.
Collapse
Affiliation(s)
- J. Zhao
- Laboratory of Advanced Separations (LAS), École Polytechnique Fédérale de Lausanne (EPFL), Sion CH-1951, Switzerland
- State Key Laboratory of Materials-Oriented Chemical Engineering, Jiangsu National Synergetic Innovation Center for Advanced Materials, College of Chemical Engineering, Nanjing Tech University, Nanjing 210009, China
| | - G. He
- Laboratory of Advanced Separations (LAS), École Polytechnique Fédérale de Lausanne (EPFL), Sion CH-1951, Switzerland
| | - S. Huang
- Laboratory of Advanced Separations (LAS), École Polytechnique Fédérale de Lausanne (EPFL), Sion CH-1951, Switzerland
| | - L. F. Villalobos
- Laboratory of Advanced Separations (LAS), École Polytechnique Fédérale de Lausanne (EPFL), Sion CH-1951, Switzerland
| | - M. Dakhchoune
- Laboratory of Advanced Separations (LAS), École Polytechnique Fédérale de Lausanne (EPFL), Sion CH-1951, Switzerland
| | - H. Bassas
- Laboratory of Advanced Separations (LAS), École Polytechnique Fédérale de Lausanne (EPFL), Sion CH-1951, Switzerland
| | - K. V. Agrawal
- Laboratory of Advanced Separations (LAS), École Polytechnique Fédérale de Lausanne (EPFL), Sion CH-1951, Switzerland
- Corresponding author.
| |
Collapse
|
27
|
Fan JG, Chen L, Li JX, Gu QJ, Li DB, Zhao LB, He G. [The treatment of nose-eye correlated diseases with external nasal incision combined with nasal cavity approach surgery through endoscope]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2018; 30:1210-1214. [PMID: 29798331 DOI: 10.13201/j.issn.1001-1781.2016.15.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 11/22/2015] [Indexed: 11/12/2022]
Abstract
Objective:To explore the indications and characteristics for the treatment of nose-eye correlated diseases with endoscopic surgery through external nasal incision combined with nasal cavity approach.Method:The clinical data of 13 patients whom hospitalized in our department and treated by endoscopic surgery through external nasal incision combined with nasal cavity approach since October 2011, were retrospectively analyzed and the characteristics of different pathological changes, clinical manifestations, surgical approach and follow-up results were summarized.Four cases of patients underwent endoscopic surgery through nasal cavity and lacrimal caruncle conjunctival incision, 4 cases received bone fracture reduction and DCR with endoscope through double path of nasal cavity and the original trauma wound, 2 cases with endoscopic bone tumor resection through nasal cavity and external nasal incision, the rest of the 3 cases with endonasal endoscopic and peri-orbit incision surgery.Result:Two cases of tumor patients showed no recurrence followed up for 1.5 to 2 years; the diplopia disappeared in 2 cases of orbital medial wall fracture; surgeries of 4 cases of orbital wall fracture with lacrimal duct obstruction patients, 3 cases succeeded, 1 case failed and change into dacryocystorhinotomy with external nasal incision, and epiphora of all patients vanished; all of the patients of sinus osteoma, foreign bodies and abscess were cured and symptoms disappeared; the symptoms of ectopic meningioma patient gradually died down with eyebrow scars left.Conclusion:The surgery with external nasal incision combined with nasal cavity approach through endoscope to treat noseeye correlated diseases can effectively deal with relevant pathological changes, with the advantages of clear operation field and less damage, but its exact indications and surgical methods still need to be further explored.
Collapse
Affiliation(s)
- J G Fan
- Department of Otorhinolaryngology Head and Neck Surgery, Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital,Chengdu,610072,China
| | - L Chen
- Department of Ophthalmology, Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital
| | - J X Li
- Department of Otorhinolaryngology Head and Neck Surgery, Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital,Chengdu,610072,China
| | - Q J Gu
- Department of Otorhinolaryngology Head and Neck Surgery, Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital,Chengdu,610072,China
| | - D B Li
- Department of Otorhinolaryngology Head and Neck Surgery, Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital,Chengdu,610072,China
| | - L B Zhao
- Department of Otorhinolaryngology Head and Neck Surgery, Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital,Chengdu,610072,China
| | - G He
- Department of Otorhinolaryngology Head and Neck Surgery, Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital,Chengdu,610072,China
| |
Collapse
|
28
|
Bacha JA, He G, Xie X, Steino A, Brown DM, Siddik ZH. Abstract A01: Distinct mechanism of action of DNA-damaging agent dianhydrogalactitol (VAL-083) suggests combination therapy with PARP inhibitors. Clin Cancer Res 2018. [DOI: 10.1158/1557-3265.ovca17-a01] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
DNA damage response (DDR) is a network of intracellular pathways designed to minimize the impact of DNA damage. Multiple DNA repair pathways are known, including mismatch repair (MMR), O6-methylguanine DNA methyltransferase (MGMT), non-homologous end joining (NHEJ), and homologous recombination (HR), which act either by repairing the damage, arresting cell growth or, if necessary, promoting cell death. DDR defects are a hallmark of cancer development, rendering the cancer cells highly sensitive to targeted DNA-damaging agents. Ovarian cancer is normally treated with platinum (Pt)-based chemotherapy, which forms predominantly intrastrand DNA crosslinks; however, most advanced ovarian cancer patients develop episodes of recurrent disease with progressively shorter disease-free intervals. Dysfunctional p53 diminishes the therapeutic cytotoxicity of many DNA-targeting drugs, including Pt-based agents, comprising a therapeutic challenge in high-grade serous ovarian cancer (HGSOC), where p53 is almost universally mutated (~96%). Attempts to overcome Pt-resistance in HGSOC include PARP inhibitors (PARPi), which target tumors with deficiencies in the HR pathway (50% of HGSOC), responsible for the repair of DNA double-strand breaks (DSBs). Unfortunately, PARPi resistance frequently arises, leading to a 5-year survival rate of only 40% in this cancer. VAL-083 is a first-in-class DNA-damaging agent that has demonstrated clinical activity against a range of tumor types, including ovarian cancer, in historical NCI-sponsored clinical studies. VAL-083 rapidly induces interstrand crosslinks at guanine-N7, causing DNA DSBs that, if left unrepaired, are lethal to the cancer cell. We have shown that VAL-083 treatment leads to DNA damage that activates HR and is independent of common DNA repair pathways, including MGMT, MMR, and NHEJ. Notably, VAL-083 induces persistent S/G2 phase cell cycle arrest through two parallel pathways--one p53-independent and one p53-dependent. Taken together, these data propose the potential for targeting HR-impaired tumors and for combination treatment with S-phase specific DNA-targeting agents, including PARPi. We have previously seen VAL-083 cytotoxicity against a panel of ovarian cancer cells with differing p53 status and superadditivity between VAL-083 and PARPi olaparib, in vitro. The purpose of this study was to expand on these studies by examining the cytotoxicity of VAL-083 against HR-impaired ovarian cancer cells, the impact of p53 status, and the potential for VAL-083 combination with PARPi as part of a treatment strategy for HR-impaired, p53 dysfunctional HGSOC. VAL-083 cytotoxicity was investigated using the 5-day MTT assay in A2780 ovarian cancer cells. HR-impaired A2780 were examined using BRCA1 siRNA oligos prior to VAL-083 exposure. Combinations with PARPi veliparib (catalytic) and talazoparib (trapping) were examined in HR-proficient and HR–impaired A2780. The impact of p53 status was investigated by CRISPR/cas 9 knockout of p53 in the wildtype (wt) A2780 cells and in p53-mutated OVCAR3 cancer cells. We report increased VAL-083 cytotoxicity against HR-impaired A2780 cancer cells, further supporting HR as the main repair pathway for VAL-083-induced DNA damage, and suggesting HR-impaired HGSOC as a target for VAL-083 treatment. We further report superadditivity between VAL-083 and PARPi veliparib and talazoparib. Significantly, VAL-083 cytotoxicity against wt and knockout p53 A2780 cells and against p53-mutated OVCAR3 cells differed only by a factor of ~2, supporting a p53-independent mechanism of action for VAL-083. In conclusion, our results demonstrate a distinct DNA-damaging mechanism for VAL-083, resulting in the ability to target HR-impaired tumors and overcome MGMT- , MMR- , and NHEJ-related chemoresistance. VAL-083 activity was independent of p53 status, and superadditivity with PARPi was identified in HR-proficient A2780. Studies in HR-impaired A2780 are ongoing and will also be presented.
Citation Format: Jeffrey A. Bacha, Guangan He, Xiaolei Xie, Anne Steino, Dennis M. Brown, Zahid H. Siddik. Distinct mechanism of action of DNA-damaging agent dianhydrogalactitol (VAL-083) suggests combination therapy with PARP inhibitors. [abstract]. In: Proceedings of the AACR Conference: Addressing Critical Questions in Ovarian Cancer Research and Treatment; Oct 1-4, 2017; Pittsburgh, PA. Philadelphia (PA): AACR; Clin Cancer Res 2018;24(15_Suppl):Abstract nr A01.
Collapse
Affiliation(s)
| | - Guangan He
- 2The University of Texas MD Anderson Cancer Center, Houston, TX,
| | - Xiaolei Xie
- 2The University of Texas MD Anderson Cancer Center, Houston, TX,
| | - Anne Steino
- 1DelMar Pharmaceuticals, Vancouver, BC, Canada,
| | | | - Zahid H. Siddik
- 2The University of Texas MD Anderson Cancer Center, Houston, TX,
| |
Collapse
|
29
|
Shi M, Yu X, Wang L, Dai F, He G, Li Q. Reaction Equilibrium and Kinetics of Synthesis of Polyoxymethylene Dimethyl Ethers from Formaldehyde and Methanol. Kinet Catal 2018. [DOI: 10.1134/s0023158418030199] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
30
|
Zhai B, He G, Steino A, Bacha JA, Brown DM, Siddik Z, Daugaard M. Abstract A109: DNA-damaging agent dianhydrogalactitol (VAL-083) targets HR repair pathway and suggests combination therapy with topoisomerase and PARP inhibitors. Mol Cancer Ther 2018. [DOI: 10.1158/1535-7163.targ-17-a109] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
DNA damage repair (DDR) describes the network of pathways that are responsible for minimizing the effect of daily DNA damage such as mismatched base pairs, single-strand breaks, and double-strand breaks (DSBs). Multiple DNA repair pathways are known, including mismatch repair (MMR), O6-methylguanine DNA methyltransferase (MGMT), non-homologous end joining (NHEJ), and homologous recombination (HR), which act either by repairing the damage, arresting cell growth or, if necessary, promoting cell death. DDR defects are a hallmark of cancer development, rendering the cancer cells highly sensitive to targeted DNA-damaging agents. Dianhydrogalactitol (VAL-083) is a first-in-class DNA-damaging agent that rapidly induces interstrand crosslinks at guanine-N7 causing persistent DNA DSBs that, if left unrepaired, are lethal to the cancer cells. We have previously shown that VAL-083 treatment leads to DNA damage that activates HR and is independent of MGMT DNA repair. Furthermore, we recently showed that VAL-083 induces persistent S/G2 phase cell cycle arrest, proposing potential for combination treatment with S-phase specific DNA-targeting agents such as topoisomerase and PARP inhibitors. In this study, biochemical and microscopic analyses of DNA repair markers were employed to investigate the VAL-083-induced DNA damage response in different MMR- or NHEJ-proficient/deficient cancer cell lines. VAL-083’s activity against HR-impaired cancer cells was also investigated using BRCA1 siRNAs. VAL-083 combination with topoisomerase inhibitors, etoposide (Top2) and camptothecin (Top1), and PARP inhibitor olaparib was investigated in PC3, A549, and A2780 cancer cells. Here, we report VAL-083 is a DNA-targeting agent that induces DNA DSBs, irreversible S/G2-phase cell cycle arrest, activation of the HR repair pathway, and ultimately cell death through mechanisms independent of MGMT, MMR, and NHEJ. We also show increased VAL-083 cytotoxicity against HR-impaired (BRCA1-knockdown) A2780 cancer cells, further supporting HR as the main repair pathway involved in VAL-083-induced cancer cell death, demonstrating the potential of VAL-083 for the treatment of HR-impaired tumors. Additionally, we report synergy between VAL-083 and topoisomerase inhibitors etoposide and camptothecin in A549 and PC3 cancer cell lines, as well as superadditivity with PARP inhibitor olaparib in A2780 cancer cells. Taken together, our results demonstrate a distinct DNA-targeting mechanism of VAL-083, leading to the ability to overcome MGMT- , MMR- , and NHEJ-related chemoresistance to common DNA-targeting agents, including temozolomide and nitrosoureas. In addition, increased VAL-083 cytotoxic effect in cancer cells with impaired HR and synergy/superadditivity with topoisomerase and PARP inhibitors was identified.
Citation Format: Beibei Zhai, Guangan He, Anne Steino, Jeffrey A. Bacha, Dennis M. Brown, Zahid Siddik, Mads Daugaard. DNA-damaging agent dianhydrogalactitol (VAL-083) targets HR repair pathway and suggests combination therapy with topoisomerase and PARP inhibitors [abstract]. In: Proceedings of the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; 2017 Oct 26-30; Philadelphia, PA. Philadelphia (PA): AACR; Mol Cancer Ther 2018;17(1 Suppl):Abstract nr A109.
Collapse
Affiliation(s)
- Beibei Zhai
- 1Vancouver Prostate Center, University of British Columbia, Vancouver, British Columbia, Canada
| | - Guangan He
- 2The University of Texas MD Anderson Cancer Center, Houston, TX
| | - Anne Steino
- 3Delmar Pharmaceuticals Inc., Vancouver, British Columbia, Canada
| | - Jeffrey A. Bacha
- 3Delmar Pharmaceuticals Inc., Vancouver, British Columbia, Canada
| | | | - Zahid Siddik
- 2The University of Texas MD Anderson Cancer Center, Houston, TX
| | - Mads Daugaard
- 1Vancouver Prostate Center, University of British Columbia, Vancouver, British Columbia, Canada
| |
Collapse
|
31
|
Abstract
The total syntheses of teixobactin and a series of its stereoisomers at positions 2, 5, 6, 10 and 11 were achieved via a combined strategy of solution and solid phase peptide synthesis.
Collapse
Affiliation(s)
- L. Liu
- State Key Laboratory of Elemento-Organic Chemistry
- College of Chemistry
- Nankai University
- Tianjin 300071
- China
| | - S. Wu
- State Key Laboratory of Elemento-Organic Chemistry
- College of Chemistry
- Nankai University
- Tianjin 300071
- China
| | - Q. Wang
- State Key Laboratory of Elemento-Organic Chemistry
- College of Chemistry
- Nankai University
- Tianjin 300071
- China
| | - M. Zhang
- State Key Laboratory of Elemento-Organic Chemistry
- College of Chemistry
- Nankai University
- Tianjin 300071
- China
| | - B. Wang
- State Key Laboratory of Elemento-Organic Chemistry
- College of Chemistry
- Nankai University
- Tianjin 300071
- China
| | - G. He
- State Key Laboratory of Elemento-Organic Chemistry
- College of Chemistry
- Nankai University
- Tianjin 300071
- China
| | - G. Chen
- State Key Laboratory of Elemento-Organic Chemistry
- College of Chemistry
- Nankai University
- Tianjin 300071
- China
| |
Collapse
|
32
|
Zhai B, Golebiewska A, He G, Steino A, Bacha J, Brown D, Niclou S, Siddik Z, Daugaard M. DRES-10. THE DISTINCT CYTOTOXIC MECHANISM OF DIANHYDROGALACTITOL (VAL-083) OVERCOMES CHEMORESISTANCE AND PROVIDES NEW OPPORTUNITIES FOR COMBINATION THERAPY IN THE TREATMENT OF GLIOBLASTOMA. Neuro Oncol 2017. [DOI: 10.1093/neuonc/nox168.268] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
33
|
Mehinto AC, VanDervort DR, Lao W, He G, Denison MS, Vliet SM, Volz DC, Mazor RD, Maruya KA. High throughput in vitro and in vivo screening of inland waters of Southern California. Environ Sci Process Impacts 2017; 19:1142-1149. [PMID: 28612856 DOI: 10.1039/c7em00170c] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
The impact of unmonitored contaminants, also known as contaminants of emerging concern (CECs), on freshwater streams remains largely uncharacterized. Water samples from 31 streams representing urban, agricultural and undeveloped (i.e., open space) land use in Southern California (USA) were analyzed for in vitro and in vivo bioactivity. The extent and magnitude of bioactivity screened using endocrine-responsive cell bioassays and a fish embryo screening assay were low. In contrast, a wider gradient of responses for the aryl hydrocarbon receptor (AhR) assay was observed, which was negatively correlated with a measure of benthic community structure. Both aromatic and non-aromatic CECs were tentatively identified in these samples, but polycyclic aromatic hydrocarbons (PAHs), known AhR agonists in urban environments, were not present at detectable levels. These results suggest that a combination of in vitro and in vivo show potential as screening techniques for biological condition in situ, but that more advanced, comprehensive analytical methods are needed to identify bioactive contaminants.
Collapse
Affiliation(s)
- A C Mehinto
- Southern California Coastal Water Research Project, Costa Mesa, CA, USA
| | | | | | | | | | | | | | | | | |
Collapse
|
34
|
Tang YK, He G, Fan JG, Zhu W. [The study of locating facial nerve precisely in middle ear surgery based on clinical anatomy]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2017; 31:1334-1337. [PMID: 29798225 DOI: 10.13201/j.issn.1001-1781.2017.17.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 06/18/2017] [Indexed: 11/12/2022]
Abstract
Objective:To investigate the methods of locating facial nerve precisely in middle ear surgery through the observation and measurement of the facial nerve and surrounding anatomical structures and to provide reference for the middle ear surgery.Method:Combined surgical approach on 15 cases (30 sides) fresh adult cadaveric specimens were dissected, observed the characteristics of facial nerve and its shape and spatial relationship of the surrounding structures, and measured the distance between the facial nerve and its surrounding structures.Result:The shortest distance from the midpoint of the posterior wall of external auditory canal (annulus level) to the vertical segment of the facial nerve was (3.37±0.34)mm, the shortest distance from the leading edge of the sigmoid sinus to the vertical segment of facial nerve was (7.40±0.71)mm, the shortest distance from the lateral margin of jugular bulb to the facial nerve was (5.58±0.79)mm, the shortest distance from Henle crest to the pyramidal segment of facial nerve was (12.76±1.24)mm, the shortest distance between the pyramidal segment of facial nerve and the posterior short limb of incus was (1.56±0.35)mm, the shortest distance between the pyramidal segment of facial nerve and the lower edge of posterior semicircular canal was (2.56±0.41) mm, the shortest distance between the lower edge of horizontal semicircular canal and the horizontal segment of facial nerve was (1.28±0.32) mm, the shortest distance between the upper edge of vestibular window and the horizontal segment of facial nerve was (0.67±0.15)mm.Conclusion:A good command of the anatomy of temporal bone as well as the methods of locating facial nerve will provide the key to reduce the probability of iatrogenic facial nerve injury in middle ear surgery.
Collapse
Affiliation(s)
- Y K Tang
- Department of Otorhinolaryngology Head and Neck Surgery, Sichuan Provincial People's Hospital, the Affiliated Hospital, University of Electronic Science and Technology of China, Chengdu, 610000, China
| | - G He
- Department of Otorhinolaryngology Head and Neck Surgery, Sichuan Provincial People's Hospital, the Affiliated Hospital, University of Electronic Science and Technology of China, Chengdu, 610000, China
| | - J G Fan
- Department of Otorhinolaryngology Head and Neck Surgery, Sichuan Provincial People's Hospital, the Affiliated Hospital, University of Electronic Science and Technology of China, Chengdu, 610000, China
| | - W Zhu
- Department of Anatomy, West China Medical College of Sichuan University
| |
Collapse
|
35
|
Steino A, He G, Bacha JA, Brown DM, Siddik Z. Abstract 1429: DNA damage response to dianhydrogalactitol (VAL-083) in p53-deficient non-small cell lung cancer cells. Cancer Res 2017. [DOI: 10.1158/1538-7445.am2017-1429] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Non-small cell lung cancer (NSCLC) treatment usually involves surgery and chemotherapy with tyrosine kinase inhibitors (TKI) in patients with EGFR mutations (10-15% in Western population, 40% in Asian populations) or with platinum-based regimens. Response to TKI treatment is short lived, and tumors recur with new mutations, primarily T790M. Recurrent NSCLC with T790M is sensitive to third generation TKIs, but resistance usually emerges through new mutations, including KRAS. Resistance to cisplatin and carboplatin, partly due to p53 mutation, is also a major clinical limitation and long-term prognosis in NSCLC is poor. Dianhydrogalactitol (VAL-083) is a bi-functional alkylating agent with demonstrated clinical activity against NSCLC in historical NCI-sponsored trials and VAL-083 is approved for lung cancer treatment in China. However, the mechanism-of-action of how DNA damage signals are propagated and their effects on NSCLC cells are not fully understood. Therefore, we examined VAL-083 in a panel of 11 human NSCLC cell lines harboring wild-type p53 (H460, A549, H226), mutant p53 (H1975, SkLU1, H2122, H157, H1792, H23) or null p53 (H838, H1299). Importantly, as determined by the 5-day MTT assay, VAL-083 was cytotoxic against all 11 cell lines at low μM concentrations and cytotoxicity was independent of p53 status. We chose 3 TKI-resistant cell lines with different mutation profiles for cell cycle kinetics studies: i) H1975 (p53 mut, EGFR-T790M mut, KRAS wt) with IC50 0.9μM, ii) A549 (p53 wt, EGFR wt, KRAS mut) with IC50 1.8μM, and iii) H157 (p53 mut, EGFR wt, KRAS mut) with IC50 4.5μM. In all 3 cell lines, early response at 18 hr showed dose-dependent increase in cells in S-phase, with continued slow cell cycle progression resulting in accumulation of cells in G2/M phase by 36 hr, suggesting persistent cell cycle arrest. DNA damage signaling was examined by immunoblot analysis in A549 and H1975 cells. In p53-wt A549, VAL-083 induced the phospho-Ser15 form of p53, total p53 and total p21, thus indicating that VAL-083 treatment activated p53 function. On the other hand, in p53-mutant H1975, VAL-083 treatment did not result in consistent p53 or p21 increases, but did readily induce phospho-Ser15 p53. This is consistent with a lack of p53 function, as anticipated for mutant p53 cells. Interestingly, H1975 was 2-fold more sensitive to VAL-083 than A549, suggesting, that in p53-mutant cells, VAL-083 acts through a p53-independent mechanism. Examination of ATR, ATM, Chk1 and Chk2 indicated that DNA damage by VAL-083 prompted phosphorylation of these kinases. Notably, the total anti-apoptotic Chk1 was more prominently reduced in H1975 than A549, which may partly explain the stronger cytotoxicity of VAL-083 in p53-mutant H1975. These preclinical data strongly support VAL-083 as a potential treatment of mutant p53 and TKI-resistant NSCLC, and indicate DNA damage signaling is mediated via ATM, ATR, Chk1 and Chk2.
Citation Format: Anne Steino, Guangan He, Jeffrey A. Bacha, Dennis M. Brown, Zahid Siddik. DNA damage response to dianhydrogalactitol (VAL-083) in p53-deficient non-small cell lung cancer cells [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 1429. doi:10.1158/1538-7445.AM2017-1429
Collapse
Affiliation(s)
- Anne Steino
- 1DelMar pharmaceuticals, Inc., Vancouver, British Columbia, Canada
| | - Guangan He
- 2The University of Texas MD Anderson Cancer Center, Houston, TX
| | - Jeffrey A. Bacha
- 1DelMar pharmaceuticals, Inc., Vancouver, British Columbia, Canada
| | - Dennis M. Brown
- 1DelMar pharmaceuticals, Inc., Vancouver, British Columbia, Canada
| | - Zahid Siddik
- 2The University of Texas MD Anderson Cancer Center, Houston, TX
| |
Collapse
|
36
|
Yan L, He G, Zhou X, Zheng Y, Zhu Y, Yang J, Zhang M, Zhou Y. Contrast-enhanced ultrasound in the diagnosis of orbital space-occupying lesions. Clin Radiol 2017; 72:798.e1-798.e6. [PMID: 28464984 DOI: 10.1016/j.crad.2017.03.026] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2016] [Revised: 02/22/2017] [Accepted: 03/30/2017] [Indexed: 12/29/2022]
Abstract
AIM To summarise the sonographic findings and assess the feasibility of contrast-enhanced ultrasound (CEUS) as an imaging method for the diagnosis of orbital space-occupying lesions. MATERIALS AND METHODS This was a prospective study of 53 patients who underwent orbital ultrasound at Xijing Hospital. Two-dimensional ultrasound, colour Doppler flow imaging (CDFI), and CEUS imaging were obtained and compared in patients with orbital haemangioma, pseudotumour, melanoma of the choroid, and retinoblastoma. RESULTS CEUS imaging cannot only visualise the location, shape, border, acoustic properties of a lesion, and interactions between the lesion and surrounding tissues, but also display the microvasculature and tissue perfusion within the lesion. The information obtained from CEUS imaging is valuable for diagnosis and differential diagnosis of orbital space-occupying lesions. CONCLUSION CEUS imaging allowed better visualisation of the lesions, enabled detection of vascular changes, increased the signal-to-noise ratio, and increased the sensitivity of detection of changes in perfusion in the microcirculation. It has relatively high sensitivity and specificity in the diagnosis of orbital space-occupying lesions and increases the accuracy of diagnosis.
Collapse
Affiliation(s)
- L Yan
- Department of Ultrasonography, Xijing Hospital, The Fourth Military Medical University, No. 17 West Changle Road, Xi'an 710032, China; Department of Ultrasonography, Xi'an Central Hospital, The Third Affiliated Hospital of JiaoTong University, No. 185 Houzai Gate, Xi'an 710003, China
| | - G He
- Department of Ultrasonography, Xijing Hospital, The Fourth Military Medical University, No. 17 West Changle Road, Xi'an 710032, China
| | - X Zhou
- Department of Ultrasonography, Xijing Hospital, The Fourth Military Medical University, No. 17 West Changle Road, Xi'an 710032, China.
| | - Y Zheng
- Department of Ultrasonography, Xi'an Central Hospital, The Third Affiliated Hospital of JiaoTong University, No. 185 Houzai Gate, Xi'an 710003, China
| | - Y Zhu
- Department of Ultrasonography, Xi'an Central Hospital, The Third Affiliated Hospital of JiaoTong University, No. 185 Houzai Gate, Xi'an 710003, China
| | - J Yang
- Department of CT & MRI, Xi'an Central Hospital, The Third Affiliated Hospital of JiaoTong University, No. 185 Houzai Gate, Xi'an 710003, China
| | - M Zhang
- Department of Ultrasonography, Xijing Hospital, The Fourth Military Medical University, No. 17 West Changle Road, Xi'an 710032, China
| | - Y Zhou
- Department of Ultrasonography, Xi'an Central Hospital, The Third Affiliated Hospital of JiaoTong University, No. 185 Houzai Gate, Xi'an 710003, China
| |
Collapse
|
37
|
Zhang H, He G, Kong Y, Chen Y, Wang B, Sun X, Jia B, Xie X, Wang X, Chen D, Wei L, Zhang M, Zeng H, Chen H. Tumour-activated liver stromal cells regulate myeloid-derived suppressor cells accumulation in the liver. Clin Exp Immunol 2017; 188:96-108. [PMID: 28019655 DOI: 10.1111/cei.12917] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/12/2016] [Indexed: 12/13/2022] Open
Abstract
Regulating mechanisms underlying hepatic myeloid-derived suppressor cell (MDSC) accumulation remain to be described. Here, we provide evidence for the involvement of tumour-activated liver stromal cells in the process of hepatic MDSCs migration and accumulation. Our data showed an elevated frequency of MDSCs in the liver of tumour-bearing mice. Moreover, tumour-activated liver stromal cells promote MDSC migration into the liver site. Further investigation indicated higher levels of cytokine and chemokine expression in liver stromal cells after exposure to the tumour-conditioned supernatant. Notably, the expression levels of proinflammatory factors, mainly including macrophage colony stimulating factor (M-CSF), transforming growth factor-β (TGF-β), monocyte chemotactic protein-1 (MCP-1) and stromal-derived factor-1 (SDF-1), increased after treatment with tumour-conditioned supernatant, and blockade of MCP-1 or SDF-1 decreased the proportion of tumour infiltrated MDSCs in mice co-transplanted with liver stromal cells and tumour cells, but not in mice with only tumour cells injection. These findings demonstrate that tumour-activated liver stromal cells produce higher levels of chemokines and cytokines, which may contribute to MDSC accumulation into the liver site in patients with liver cancer.
Collapse
Affiliation(s)
- H Zhang
- Peking University People's Hospital, Peking University Hepatology Institute, Beijing, China.,Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing, China.,Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.,Beijing Key Laboratory of Emerging Infectious Diseases, Beijing, China
| | - G He
- Peking University People's Hospital, Peking University Hepatology Institute, Beijing, China.,Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing, China
| | - Y Kong
- Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.,Beijing Key Laboratory of Emerging Infectious Diseases, Beijing, China
| | - Y Chen
- Peking University People's Hospital, Peking University Hepatology Institute, Beijing, China.,Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing, China
| | - B Wang
- Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.,Beijing Key Laboratory of Emerging Infectious Diseases, Beijing, China
| | - X Sun
- Peking University People's Hospital, Peking University Hepatology Institute, Beijing, China.,Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing, China
| | - B Jia
- Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.,Beijing Key Laboratory of Emerging Infectious Diseases, Beijing, China
| | - X Xie
- Peking University People's Hospital, Peking University Hepatology Institute, Beijing, China.,Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing, China
| | - X Wang
- Peking University People's Hospital, Peking University Hepatology Institute, Beijing, China.,Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing, China
| | - D Chen
- Institute of Immunology, Tsinghua University School of Medicine, Beijing, China
| | - L Wei
- Peking University People's Hospital, Peking University Hepatology Institute, Beijing, China.,Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing, China
| | - M Zhang
- Institute of Immunology, Tsinghua University School of Medicine, Beijing, China
| | - H Zeng
- Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.,Beijing Key Laboratory of Emerging Infectious Diseases, Beijing, China
| | - H Chen
- Peking University People's Hospital, Peking University Hepatology Institute, Beijing, China.,Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing, China
| |
Collapse
|
38
|
Zheng Z, Zhang P, He G, Liao K, Wang Z, Pan J, Du K, Du J, Li BA. Simultaneous detection of 45 fusion genes in leukemia by dual-color fluorescence real-time PCR. Int J Lab Hematol 2017; 39:175-184. [PMID: 28133905 DOI: 10.1111/ijlh.12600] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/19/2016] [Accepted: 10/03/2016] [Indexed: 11/28/2022]
Abstract
INTRODUCTION Detection of recurrent genetic abnormalities is of great significance for a refined diagnosis and assessment of prognosis in leukemia. Conventional nested reverse transcription PCR is labor intensive and time-consuming. METHODS We have developed a novel dual-color TaqMan probe-based real-time PCR method for the simultaneous screening of 45 fusion transcripts in 12 parallel reactions. The method was tested and validated with cell lines carrying known fusion transcripts and patient samples. RESULTS A multiplex real-time PCR method was successfully developed for rapid detection of 45 fusion genes and validated for 15 of the more commonly detected fusion genes. Intra-assay reproducibility assessed for the most frequent rearrangements ranged from 0.41% to 0.74% for the coefficient of variation (CV) of cycle threshold (Ct) and the interassay reproducibility ranged from 1.62% to 2.83% in five separate experiments. The lowest detection limit for the translocations tested ranged between 1 : 16 000 and 1 : 32 000. Validation of the method with 213 patient samples showed 100% specificity and excellent consistence with conventional nested RT-PCR. CONCLUSION Overall, we believe that this method is easily applicable, cost-effective, and clinically useful for a rapid screening of fusion genes in the initial diagnostic phase of leukemia. Its use can also be extended to the monitoring of minimal residual disease.
Collapse
Affiliation(s)
- Z Zheng
- School of Life Sciences, Xiamen University, Xiamen, China
| | - P Zhang
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - G He
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - K Liao
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - Z Wang
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - J Pan
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - K Du
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - J Du
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
| | - B-A Li
- School of Life Sciences, Xiamen University, Xiamen, China
| |
Collapse
|
39
|
Steino A, He G, Zhai B, Bacha J, Lu S, Brown D, Daugaard M, Siddik Z. P3.02c-007 Assessment of Dianhydrogalactitol in the Treatment of Relapsed or Refractory Non-Small Cell Lung Cancer. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2016.11.1802] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
40
|
Xie X, He G, Siddik ZH. Functional Activation of Mutant p53 by Platinum Analogues in Cisplatin-Resistant Cells Is Dependent on Phosphorylation. Mol Cancer Res 2016; 15:328-339. [PMID: 28031409 DOI: 10.1158/1541-7786.mcr-16-0257-t] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2016] [Revised: 11/22/2016] [Accepted: 11/29/2016] [Indexed: 02/01/2023]
Abstract
Dysfunctionality of the p53 tumor suppressor is a major cause of therapeutic drug resistance in cancer. Recently, we reported that mutant, but otherwise functional, p53v172F was inactivated in cisplatin-resistant 2780CP/Cl-16 and 2780CP/Cl-24 human ovarian tumor cells by increased recruitment of the inhibitor MDM4. The current study demonstrates that, unlike cisplatin, platinum analogues oxaliplatin and DACH-diacetato-dichloro-Pt(IV) (DAP) strongly stabilize and activate p53v172F in resistant cells, as indicated by prolonged p53 half-life and transactivation of targets p21 (CDKN1A) and MDM2. This increase in MDM2 reduced MDM4 levels in cell lysates as well as the p53 immunocomplex and prevented reversion of p53 to the inactive p53-MDM2-MDM4-bound state. Phosphorylation of p53 at Ser15 was demonstrated by all three drugs in sensitive A2780 and corresponding resistant 2780CP/Cl-16 and 2780CP/Cl-24 cell lines. However, cisplatin induced Ser20 phosphorylation in A2780 cells only, but not in resistant cells; in contrast, both DAP and oxaliplatin induced this phosphorylation in all three cell lines. The inference that Ser20 phosphorylation is more important for p53 activation was confirmed by ectopic expression of a phosphomimetic (S20D) mutant p53 that displayed reduced binding, relative to wild-type p53, to both MDM2 and MDM4 in p53-knockout A2780 cells. In consonance, temporal studies demonstrated drug-induced Ser15 phosphorylation coincided with p53 stabilization, whereas Ser20 phosphorylation coincided with p53 transactivation.Implications: Cisplatin fails to activate the pathway involved in phosphorylating mutant p53v172F at Ser20 in resistant cells, but this phosphorylation is restored by oxaliplatin and DAP that reactivates p53 function and circumvents cisplatin resistance. Mol Cancer Res; 15(3); 328-39. ©2016 AACR.
Collapse
Affiliation(s)
- Xiaolei Xie
- Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas
| | - Guangan He
- Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas
| | - Zahid H Siddik
- Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
| |
Collapse
|
41
|
Fan JG, Lin W, Chen L, Li JX, Gu QJ, Li DB, Zhao LB, He G. [Endonasal endoscopic surgery in treatment of medial recus muscle entrapment: the management and effectiveness]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2016; 30:1630-1633. [PMID: 29871160 DOI: 10.13201/j.issn.1001-1781.2016.20.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 04/25/2016] [Indexed: 11/12/2022]
Abstract
Objective:To explore the indications , surgery method and effect for the treatment of medial rectus muscle entrapment with endoscopic surgery.Method: Eight medial rectus muscle entrapment patients were enrolled in this study,3 cases underwent obital medial wall fracture reposition and medial rectus muscle adhesion decomposition surgery through endonasal endoscope,and 5 cases received obital medial wall fracture reposition surgery with endoscope through nasal cavity and lacrimal caruncle conjunctival incision. Result:The diplopia disappeared and eyeball abduction function recovered in 6 cases of medial rectus muscle entrapment patients within 2 months,and 1 case with each surgery had mild diplopia and eyeball incomplete abduction left.Conclusion:Adopting endonasal endoscopic surgery or dual approaches surgery with endonasal endoscopic and transcaruncular surgery were ideal methods for medial rectus muscle entrapment diseases.Surgery with endoscope has the characteristics of clear field and less damage.The surgery should be performed whithin 3 weeks, and the entrapment of medial rectus muscle can be resoved effectively.
Collapse
Affiliation(s)
- J G Fan
- Department of Otorhinolaryngology Head and Neck Surgery, Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital,Chengdu,610072,China
| | - W Lin
- Department of Ophthalmology, Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital
| | - L Chen
- Department of Ophthalmology, Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital
| | - J X Li
- Department of Otorhinolaryngology Head and Neck Surgery, Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital,Chengdu,610072,China
| | - Q J Gu
- Department of Otorhinolaryngology Head and Neck Surgery, Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital,Chengdu,610072,China
| | - D B Li
- Department of Otorhinolaryngology Head and Neck Surgery, Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital,Chengdu,610072,China
| | - L B Zhao
- Department of Otorhinolaryngology Head and Neck Surgery, Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital,Chengdu,610072,China
| | - G He
- Department of Otorhinolaryngology Head and Neck Surgery, Sichuan Academy of Medical Science and Sichuan Provincial People's Hospital,Chengdu,610072,China
| |
Collapse
|
42
|
He G, Ramamoorthy H, Kwan CP, Lee YH, Nathawat J, Somphonsane R, Matsunaga M, Higuchi A, Yamanaka T, Aoki N, Gong Y, Zhang X, Vajtai R, Ajayan PM, Bird JP. Thermally Assisted Nonvolatile Memory in Monolayer MoS 2 Transistors. Nano Lett 2016; 16:6445-6451. [PMID: 27680095 DOI: 10.1021/acs.nanolett.6b02905] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
We demonstrate a novel form of thermally-assisted hysteresis in the transfer curves of monolayer MoS2 FETs, characterized by the appearance of a large gate-voltage window and distinct current levels that differ by a factor of ∼102. The hysteresis emerges for temperatures in excess of 400 K and, from studies in which the gate-voltage sweep parameters are varied, appears to be related to charge injection into the SiO2 gate dielectric. The thermally-assisted memory is strongly suppressed in equivalent measurements performed on bilayer transistors, suggesting that weak screening in the monolayer system plays a vital role in generating its strongly sensitive response to the charge-injection process. By exploiting the full features of the hysteretic transfer curves, programmable memory operation is demonstrated. The essential principles demonstrated here point the way to a new class of thermally assisted memories based on atomically thin two-dimensional semiconductors.
Collapse
Affiliation(s)
- G He
- Department of Electrical Engineering, University at Buffalo, The State University of New York , Buffalo, New York 14260-1900, United States
| | - H Ramamoorthy
- Department of Electrical Engineering, University at Buffalo, The State University of New York , Buffalo, New York 14260-1900, United States
| | - C-P Kwan
- Department of Physics, University at Buffalo, The State University of New York , Buffalo, New York 14260-1500, United States
| | - Y-H Lee
- Department of Electrical Engineering, University at Buffalo, The State University of New York , Buffalo, New York 14260-1900, United States
| | - J Nathawat
- Department of Electrical Engineering, University at Buffalo, The State University of New York , Buffalo, New York 14260-1900, United States
| | - R Somphonsane
- Department of Physics, King Mongkut's Institute of Technology Ladkrabang , Bangkok 10520, Thailand
| | - M Matsunaga
- Graduate School of Advanced Integration Science, Chiba University , 1-33 Yayoi-cho, Inage-ku, Chiba 263-8522, Japan
| | - A Higuchi
- Graduate School of Advanced Integration Science, Chiba University , 1-33 Yayoi-cho, Inage-ku, Chiba 263-8522, Japan
| | - T Yamanaka
- Graduate School of Advanced Integration Science, Chiba University , 1-33 Yayoi-cho, Inage-ku, Chiba 263-8522, Japan
| | - N Aoki
- Graduate School of Advanced Integration Science, Chiba University , 1-33 Yayoi-cho, Inage-ku, Chiba 263-8522, Japan
| | - Y Gong
- Department of Materials Science and NanoEngineering, Rice University , Houston, Texas 77005, United States
| | - X Zhang
- Department of Materials Science and NanoEngineering, Rice University , Houston, Texas 77005, United States
| | - R Vajtai
- Department of Materials Science and NanoEngineering, Rice University , Houston, Texas 77005, United States
| | - P M Ajayan
- Department of Materials Science and NanoEngineering, Rice University , Houston, Texas 77005, United States
| | - J P Bird
- Department of Electrical Engineering, University at Buffalo, The State University of New York , Buffalo, New York 14260-1900, United States
- Graduate School of Advanced Integration Science, Chiba University , 1-33 Yayoi-cho, Inage-ku, Chiba 263-8522, Japan
| |
Collapse
|
43
|
Thiabaud G, McCall R, He G, Arambula JF, Siddik ZH, Sessler JL. Frontispiz: Activation of Platinum(IV) Prodrugs By Motexafin Gadolinium as a Redox Mediator. Angew Chem Int Ed Engl 2016. [DOI: 10.1002/ange.201684161] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Gregory Thiabaud
- Department of Chemistry and Biochemistry; University of Texas at Austin; 105 E. 24th St. Stop A5300 Austin TX 78712-1224 USA
| | - Rebecca McCall
- Department of Chemistry; Georgia Southern University; Statesboro GA 30460 USA
| | - Guangan He
- The University of Texas M. D. Anderson Cancer Center; 1515 Holcombe Blvd., Unit Number: 1950 Houston TX 77030 USA
| | | | - Zahid H. Siddik
- The University of Texas M. D. Anderson Cancer Center; 1515 Holcombe Blvd., Unit Number: 1950 Houston TX 77030 USA
| | - Jonathan L. Sessler
- Department of Chemistry and Biochemistry; University of Texas at Austin; 105 E. 24th St. Stop A5300 Austin TX 78712-1224 USA
| |
Collapse
|
44
|
Thiabaud G, McCall R, He G, Arambula JF, Siddik ZH, Sessler JL. Frontispiece: Activation of Platinum(IV) Prodrugs By Motexafin Gadolinium as a Redox Mediator. Angew Chem Int Ed Engl 2016. [DOI: 10.1002/anie.201684161] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- Gregory Thiabaud
- Department of Chemistry and Biochemistry; University of Texas at Austin; 105 E. 24th St. Stop A5300 Austin TX 78712-1224 USA
| | - Rebecca McCall
- Department of Chemistry; Georgia Southern University; Statesboro GA 30460 USA
| | - Guangan He
- The University of Texas M. D. Anderson Cancer Center; 1515 Holcombe Blvd., Unit Number: 1950 Houston TX 77030 USA
| | | | - Zahid H. Siddik
- The University of Texas M. D. Anderson Cancer Center; 1515 Holcombe Blvd., Unit Number: 1950 Houston TX 77030 USA
| | - Jonathan L. Sessler
- Department of Chemistry and Biochemistry; University of Texas at Austin; 105 E. 24th St. Stop A5300 Austin TX 78712-1224 USA
| |
Collapse
|
45
|
Thiabaud G, McCall R, He G, Arambula JF, Siddik ZH, Sessler JL. Activation of Platinum(IV) Prodrugs By Motexafin Gadolinium as a Redox Mediator. Angew Chem Int Ed Engl 2016. [DOI: 10.1002/ange.201604236] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- Gregory Thiabaud
- Department of Chemistry and Biochemistry; University of Texas at Austin; 105 E. 24th St. Stop A5300 Austin TX 78712-1224 USA
| | - Rebecca McCall
- Department of Chemistry; Georgia Southern University; Statesboro GA 30460 USA
| | - Guangan He
- The University of Texas M. D. Anderson Cancer Center; 1515 Holcombe Blvd., Unit Number: 1950 Houston TX 77030 USA
| | | | - Zahid H. Siddik
- The University of Texas M. D. Anderson Cancer Center; 1515 Holcombe Blvd., Unit Number: 1950 Houston TX 77030 USA
| | - Jonathan L. Sessler
- Department of Chemistry and Biochemistry; University of Texas at Austin; 105 E. 24th St. Stop A5300 Austin TX 78712-1224 USA
| |
Collapse
|
46
|
Thiabaud G, McCall R, He G, Arambula JF, Siddik ZH, Sessler JL. Activation of Platinum(IV) Prodrugs By Motexafin Gadolinium as a Redox Mediator. Angew Chem Int Ed Engl 2016; 55:12626-31. [PMID: 27377046 DOI: 10.1002/anie.201604236] [Citation(s) in RCA: 52] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2016] [Indexed: 01/14/2023]
Abstract
Water-soluble platinum(IV) prodrugs, which proved kinetically stable to reduction in the presence of physiological concentration of ascorbate, were quickly reduced to their active form, oxaliplatin, when co-incubated with a macrocycle metallotexaphyrin (i.e., Motexafin Gadolinium (MGd)). The reduction of Pt(IV) to Pt(II) promoted by MGd occurs in cell culture as well, leading to an increase in the antiproliferative activity of the Pt(IV) species in question. The mediated effect is proportional to the concentration of MGd and gives rise to an enhancement when the prodrug is relatively hydrophilic. MGd is known to localize/accumulate preferentially in tumor tissues. Thus, the present "activation by reduction" approach may allow for the cancer-selective enhancement in the cytotoxicity of Pt(IV) prodrugs.
Collapse
Affiliation(s)
- Gregory Thiabaud
- Department of Chemistry and Biochemistry, University of Texas at Austin, 105 E. 24th St. Stop A5300, Austin, TX, 78712-1224, USA
| | - Rebecca McCall
- Department of Chemistry, Georgia Southern University, Statesboro, GA, 30460, USA
| | - Guangan He
- The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Unit Number: 1950, Houston, TX, 77030, USA
| | - Jonathan F Arambula
- Department of Chemistry, Georgia Southern University, Statesboro, GA, 30460, USA
| | - Zahid H Siddik
- The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Unit Number: 1950, Houston, TX, 77030, USA.
| | - Jonathan L Sessler
- Department of Chemistry and Biochemistry, University of Texas at Austin, 105 E. 24th St. Stop A5300, Austin, TX, 78712-1224, USA.
| |
Collapse
|
47
|
Ao M, Qi X, Deng J, Xu G, Tang XH, He G. [Outcomes of total deafness type of idiopathic suddendeafness in different ages]. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2016; 30:929-932. [PMID: 29771056 DOI: 10.13201/j.issn.1001-1781.2016.12.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Received: 02/28/2016] [Indexed: 06/08/2023]
Abstract
Objective:This retrospective study was aimed to investigate the characteristics of hearing recovery in the complete deafness type of SSNHL(≥81 dBHL) in patients with different ages.Method:Clinical outcomes of 179 total deafness type of idiopathic sudden deafness were compared.Patients were divided into 5 groups according to age,they were,pediatric group(13 years or less),youthful group(14-44 years),middle-aged group(45-59 years),presenium group(60-74 years),senectitude group(75 years or higher).Patients were divided into 3 groups according to the initial degree of hearing loss: 81 dB group (81-89 dBHL),90 dB group(90- 99 dBHL),100 dB group(100 dBHL or higher).Routine comprehensive treatment including corticosteroids,the inner ear microcirculation improvement drugs,neurotrophic drugs,saturationoxygen and hyperbaric oxygen therapy,etc.was applied.Patients were treated in accordance with the age and body weight.Result:The percentage of youthful group(83/179,46.4%) was highest(P<0.05),middle-aged group(57/179,31.8%)followed(P<0.05),presenium group(26/179,14.5%)was lower(P<0.05),pediatric group(8/179,4.5%) and senectitude group(5/179,2.8%)were the lowest.No a complete recovery in either pediatric group or senectitude group.A complete recovery was rare in the other groups.Recovery rate of the different aged groups was similar(P>0.05).The percentage of 100 dB group(108/179,60.3%) was highest(P<0.05).The percentage of 81 dB group(39/179,21.8%)was similar to 90 dB group(32/179,17.9%)(P>0.05).Recovery rate was similar in 81 dB group(25/39,64.1%)and 90 dB group(18/32,56.2%)(P>0.05).Recovery rate of both 81 dB group and 90 dB group were greater than 100 dB group(24/108,22.2%)(P<0.05).The 100 dB group reduced the satisfactory recovery effects.There were no differences in the proportion of the patients with dizziness(95/179,53.1%)and without dizziness(84/179,46.9%)(P>0.05).Recovery rate of patients without dizziness(43/84,51.2%) was greater than with dizziness(24/95,25.3%)(P<0.05).The percentage of the patients without dizziness(31/39,79.5%)in 81 dB group was the highest(P<0.05),90 dB group(18/32,56.2%)followed(P<0.05).The percentage of the patients with dizziness in 100 dB group(73/108,67.6%)was highest(P<0.05).Recovery rate was similar in the patients without dizziness of 81 dB group(21/31,67.7%)and 90 dB group(11/18,61.1%)(P>0.05).Recovery rate of the above two groups was greater than that of 100 dB group(11/35,31.4%)(P<0.05).Conclusion:Recovery rate of the different aged groups was similar.The percentage of the patients with dizziness in 100 dB group was highest.Initial hearing threshold in excess of 100 dB reduced the satisfactory recovery in patients with total deafness type of SSNHL.Our results provided a good reference for other clinicians.
Collapse
Affiliation(s)
- M Ao
- Department of Otolaryngology,Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital,Chengdu,610072,China
| | - X Qi
- Department of Otolaryngology,Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital,Chengdu,610072,China
| | - J Deng
- Department of Otolaryngology,Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital,Chengdu,610072,China
| | - G Xu
- Department of Otolaryngology,Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital,Chengdu,610072,China
| | - X H Tang
- Department of Otolaryngology,Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital,Chengdu,610072,China
| | - G He
- Department of Otolaryngology,Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital,Chengdu,610072,China
| |
Collapse
|
48
|
Abstract
Resveratrol is a natural compound that exhibits anticancer properties. Previous studies have proved that it can inhibit the proliferation of breast cancer cell lines and upregulate some cytokines such as cyclooxygenase-2 (COX-2) and vascular endothelial growth factor (VEGF). The initiation and progression of cancer are associated with the abnormal expression of multiple cytokines. Tristetraprolin (TTP), an mRNA-binding protein, is one of the key proteins that participate in regulating cytokine expression. Two different proliferation assays on MCF-7 cells showed that the cell proliferation rate significantly reduced following treatment with resveratrol. Most importantly, we found that resveratrol promoted TTP expression at both the mRNA and protein level in a dose- and time-dependent manner. In addition, the expression of COX-2 and VEGF were significantly suppressed by resveratrol while that of inducible nitric oxide synthase (iNOS) was upregulated. Lastly, the effects of resveratrol on both MCF-7 proliferation and expression of COX-2, VEGF, and iNOS were significantly inhibited by TTP knockdown, indicating that TTP mediates the anticancer properties of resveratrol. In summary, we conclude that resveratrol inhibits the proliferation of MCF-7 cells by TTP upregulation, which is associated with downregulation of COX-2 and VEGF and upregulation of iNOS.
Collapse
Affiliation(s)
- C Li
- Department of General Surgery, The First Affiliated Hospital, University of South China, HengYang, Hunan
| | - C Tang
- Department of General Surgery, The First Affiliated Hospital, University of South China, HengYang, Hunan
| | - G He
- Department of General Surgery, The First Affiliated Hospital, University of South China, HengYang, Hunan
| |
Collapse
|
49
|
Pang H, Shi A, Li M, Xue W, Li Y, Cao G, Yan B, Dong F, Xiao W, He G, Du G, Hu X, Cheng G. Simultaneous Determination of Baicalein and Baicalin in Human Plasma by High Performance Liquid Chromatograph-Tandem Spectrometry and its Application in a Food-Effect Pharmacokinetic Study. Drug Res (Stuttg) 2016; 66:394-401. [PMID: 27022718 DOI: 10.1055/s-0035-1569446] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
Affiliation(s)
- H. Pang
- School of Pharmacy, Shenyang Pharmaceutical University, Shenyang (P.R. China)
| | - A. Shi
- Beijing Key Laboratory of Drug Clinical Risk and Personalized Medication Evaluation, Department of Pharmacy, Beijing Hospital, Beijing (P.R. China)
| | - M. Li
- Beijing Key Laboratory of Drug Clinical Risk and Personalized Medication Evaluation, Department of Pharmacy, Beijing Hospital, Beijing (P.R. China)
| | - W. Xue
- Beijing Key Laboratory of Drug Clinical Risk and Personalized Medication Evaluation, Department of Pharmacy, Beijing Hospital, Beijing (P.R. China)
| | - Y. Li
- Beijing Key Laboratory of Drug Clinical Risk and Personalized Medication Evaluation, Department of Pharmacy, Beijing Hospital, Beijing (P.R. China)
| | - G. Cao
- Beijing Key Laboratory of Drug Clinical Risk and Personalized Medication Evaluation, Department of Pharmacy, Beijing Hospital, Beijing (P.R. China)
| | - B. Yan
- Beijing Key Laboratory of Drug Clinical Risk and Personalized Medication Evaluation, Department of Pharmacy, Beijing Hospital, Beijing (P.R. China)
| | - F. Dong
- Beijing Key Laboratory of Drug Clinical Risk and Personalized Medication Evaluation, Department of Pharmacy, Beijing Hospital, Beijing (P.R. China)
| | - W. Xiao
- StateKey Laboratory of New-tech for Chinese Medicine Pharmaceutical Process, Jiangsu Kanion Pharmaceutical CO.LTD, Lianyungang, Jiangsu (P.R. China)
| | - G. He
- Beijing Key Laboratory of Drug Targets Identification and Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing (P.R. China)
| | - G. Du
- Beijing Key Laboratory of Drug Targets Identification and Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing (P.R. China)
| | - X. Hu
- Beijing Key Laboratory of Drug Clinical Risk and Personalized Medication Evaluation, Department of Pharmacy, Beijing Hospital, Beijing (P.R. China)
| | - G. Cheng
- School of Pharmacy, Shenyang Pharmaceutical University, Shenyang (P.R. China)
| |
Collapse
|
50
|
Ramamoorthy H, Somphonsane R, Radice J, He G, Kwan CP, Bird JP. Correction to "Freeing" Graphene from Its Substrate: Observing Intrinsic Velocity Saturation with Rapid Electrical Pulsing. Nano Lett 2016; 16:1514. [PMID: 26807871 DOI: 10.1021/acs.nanolett.6b00287] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
|